prednisolone has been researched along with Aortic Arteritis, Giant Cell in 328 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To measure serial interleukin (IL)-6 levels in newly diagnosed patients with giant cell arteritis (GCA), treated in a randomized controlled trial of modified-release prednisone (MR) vs immediate-release prednisolone (IR) used in a tapering regimen conforming to British Society for Rheumatology GCA guidelines." | 9.30 | Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritis. ( Aung, T; Dasgupta, B; Gayford, D; Mackerness, C; Mapplebeck, S; Miler, E; Schofield, P; Stapleton, PP; Wilson, L, 2019) |
| "A feasibility study to assess efficacy and safety of modified release (MR) prednisone (Lodotra™) compared to immediate release (IR) prednisolone in patients with newly diagnosed giant cell arteritis (GCA)." | 9.27 | A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis. ( Achilleos, K; Dasgupta, B; Gayford, D; Mackerness, C; Mapplebeck, S; Maw, WW; Merinopoulos, D; Raine, C; Schofield, P; Stapleton, PP, 2018) |
| "Altogether forty-four patients with giant cell arteritis (GCA) were randomly allocated to either daily morning or alternate-day administration of prednisolone." | 9.07 | Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis. ( Bengtsson, BA; Hansson, T; Jonson, R; Nordborg, E; Szücs, J, 1993) |
| "To evaluate the effectiveness of leflunomide as a steroid-sparing agent among Indian patients with giant cell arteritis (GCA) and to assess the changes of "halo sign" within affected arteries, detected ultrasonographically, after remission." | 8.12 | Efficacy of leflunomide as a steroid-sparing agent in treatment of Indian giant cell arteritis patients: A 2-year follow-up study. ( Das, S; Datta, A; Ghosal, A; Goswami, RP; Sarkar, S; Sinha, D, 2022) |
| "To evaluate the efficacy of a fast track clinic (FTC) for patients suspected of polymyalgia rheumatica (PMR) regarding symptom duration, prednisolone initiation before rheumatological assessment, number of hospital contacts before diagnosis, and cancer diagnosis." | 8.02 | Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiation. ( Dam, M; Frølund, LL; Keller, KK; Kjær, SG; Nielsen, BD; Våben, C; Østgård, RD, 2021) |
| "Reduction in jaw opening is a neglected symptom of giant cell arteritis (GCA) in clinical practice and in the scientific literature." | 7.77 | Reduction in jaw opening: a neglected symptom of giant cell arteritis. ( Berlit, P; Herold, M; Kraemer, M; Metz, A; Venker, C, 2011) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 6.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| "We report a case of superinfection of liver cysts caused by Candida albicans and Staphylococcus lugdunensis in a patient with autosomal dominant polycystic kidney disease." | 5.56 | Candida albicans and Staphylococcus lugdunensis superinfection of liver cysts in a patient with autosomal dominant polycystic kidney disease under prednisolone treatment. ( Hiramatsu, R; Iijima, T; Inui, K; Mizuno, H; Sawa, N; Suwabe, T; Takaichi, K; Ubara, Y; Yamanouchi, M, 2020) |
| "To measure serial interleukin (IL)-6 levels in newly diagnosed patients with giant cell arteritis (GCA), treated in a randomized controlled trial of modified-release prednisone (MR) vs immediate-release prednisolone (IR) used in a tapering regimen conforming to British Society for Rheumatology GCA guidelines." | 5.30 | Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritis. ( Aung, T; Dasgupta, B; Gayford, D; Mackerness, C; Mapplebeck, S; Miler, E; Schofield, P; Stapleton, PP; Wilson, L, 2019) |
| "A feasibility study to assess efficacy and safety of modified release (MR) prednisone (Lodotra™) compared to immediate release (IR) prednisolone in patients with newly diagnosed giant cell arteritis (GCA)." | 5.27 | A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis. ( Achilleos, K; Dasgupta, B; Gayford, D; Mackerness, C; Mapplebeck, S; Maw, WW; Merinopoulos, D; Raine, C; Schofield, P; Stapleton, PP, 2018) |
| "Between March 3, 2012, and Sept 9, 2014, 20 patients were randomly assigned to receive tocilizumab and prednisolone, and ten patients to receive placebo and glucocorticoid; 16 (80%) and seven (70%) patients, respectively, had new-onset giant cell arteritis." | 5.22 | Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. ( Adler, S; Bütikofer, L; Dan, D; Fiege, V; Kuchen, S; Reichenbach, S; Seitz, M; Villiger, PM; Wermelinger, F, 2016) |
| "Altogether forty-four patients with giant cell arteritis (GCA) were randomly allocated to either daily morning or alternate-day administration of prednisolone." | 5.07 | Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis. ( Bengtsson, BA; Hansson, T; Jonson, R; Nordborg, E; Szücs, J, 1993) |
| "To evaluate the effectiveness of leflunomide as a steroid-sparing agent among Indian patients with giant cell arteritis (GCA) and to assess the changes of "halo sign" within affected arteries, detected ultrasonographically, after remission." | 4.12 | Efficacy of leflunomide as a steroid-sparing agent in treatment of Indian giant cell arteritis patients: A 2-year follow-up study. ( Das, S; Datta, A; Ghosal, A; Goswami, RP; Sarkar, S; Sinha, D, 2022) |
| "To evaluate the efficacy of a fast track clinic (FTC) for patients suspected of polymyalgia rheumatica (PMR) regarding symptom duration, prednisolone initiation before rheumatological assessment, number of hospital contacts before diagnosis, and cancer diagnosis." | 4.02 | Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiation. ( Dam, M; Frølund, LL; Keller, KK; Kjær, SG; Nielsen, BD; Våben, C; Østgård, RD, 2021) |
| "We quantified the excess risk of all-cause, bacterial, viral, parasitic and fungal infection conferred by oral glucocorticoids in people with polymyalgia rheumatica or giant cell arteritis and found strong dose responses for all types, even at daily doses of less than 5 mg prednisolone." | 3.91 | Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England. ( Keeley, A; Mallen, C; Morgan, AW; Pujades-Rodriguez, M; Wu, J, 2019) |
| " Ocular inflammation presented as episcleritis, scleritis, or anterior uveitis, and it emerged during the tapering of low-dose prednisolone prescribed for polymyalgia rheumatica in all patients." | 3.88 | Ocular Inflammation Associated with Polymyalgia Rheumatica without Concomitant Giant-Cell Arteritis: A Report of Three Cases. ( Arai, T; Kaburaki, T; Tanaka, R, 2018) |
| "We conducted a series of nested case-control analyses in GCA patients to examine the effect of increasing dose of prednisolone on the risk of developing diabetes, glaucoma, osteoporosis, fractures, serious infection requiring hospitalization, and death." | 3.85 | Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis. ( Collinson, N; Jick, SS; Klearman, M; Meier, CR; Musselman, D; Napalkov, P; Sarsour, K; Stone, JH; Tuckwell, K; Wilson, JC, 2017) |
| "To establish the incidence of giant cell arteritis (GCA), cumulative use of prednisolone, and comorbidities most associated with GCA." | 3.81 | Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities. ( Collinson, N; Napalkov, P; Nevitt, A; Petri, H; Sarsour, K, 2015) |
| "Reduction in jaw opening is a neglected symptom of giant cell arteritis (GCA) in clinical practice and in the scientific literature." | 3.77 | Reduction in jaw opening: a neglected symptom of giant cell arteritis. ( Berlit, P; Herold, M; Kraemer, M; Metz, A; Venker, C, 2011) |
| " A 67-year-old woman, who had been treated with 5 mg of oral prednisolone every other day for polymyalgia rheumatica, developed painful egg-sized regions of necrosis on both of her temples." | 3.72 | Bilateral scalp necrosis with giant cell arteritis. ( Hakamada, A; Isoda, K; Matsushima, M; Mizutani, H; Mori, H; Murakami, T; Yamanaka, K, 2003) |
| "The average initial dose of prednisolone in polymyalgia rheumatica was 35 mg; 51 of 62 patients were given a starting dose exceeding 15 mg." | 3.72 | [Treatment and diagnosis of polymyalgia rheumatica and temporal arteritis]. ( Gran, JT, 2003) |
| "The objective of the study was to examine bone mineral density (BMD) in patients with polymyalgia rheumatica (PMR) or temporal arteritis (TA) currently or previously treated with prednisolone." | 3.70 | No permanent reduction in bone mineral density during treatment of polymyalgia rheumatica and temporal arteritis using low dose corticosteroids. ( Dovland, H; Gran, JT; Haugeberg, G; Mikkelsen, B; Myklebust, G, 2000) |
| "Ninety-six patients with giant cell arteritis (GCA) seen from 1968 to 1985 were studied with regard to the starting dose of prednisolone and the development of serious ocular complications, which proved to be very few after treatment was started." | 3.68 | Prevention of blindness in giant cell arteritis by corticosteroid treatment. ( Myles, AB; Perera, T; Ridley, MG, 1992) |
| "Thirty one patients with giant cell arteritis (GCA) receiving standardised prednisolone treatment were followed up for one year with analyses of plasma viscosity, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), and fibrinogen concentration." | 3.68 | Plasma viscosity in giant cell arteritis as a predictor of disease activity. ( Bengtsson, BA; Bjelle, A; Gudmundsson, M; Nordborg, E, 1993) |
| "A prospective serial study of 13 well-documented, previously untreated cases of polymyalgia rheumatica was undertaken in order to assess the behavior of the nonspecific indices of disease activity, erythrocyte sedimentation rate and serum C-reactive protein (CRP) concentration, during induction of disease remission by prednisolone therapy." | 3.67 | Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study. ( Berry, H; Hind, CR; Mallya, RK; Pepys, MB, 1985) |
| "The erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), fibrinogen and haptoglobin were followed weekly during the initial phase of corticosteroid treatment in 18 patients with 19 episodes of giant cell arteritis (GCA)." | 3.67 | Acute phase reactants in the initial phase of giant cell arteritis. ( Andersson, R; Bengtsson, BA; Malmvall, BE, 1986) |
| "Treatment with leflunomide or low doses of glucocorticoids were not associated with severe course in our cohort." | 2.82 | COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia. ( Hočevar, A; Ješe, R; Kramarič, J; Rotar, Ž; Tomšič, M, 2022) |
| " Secondary end points were time to first relapse, biomarkers, cumulative glucocorticosteroid dose, and the number of patients who remained relapse-free while the glucocorticosteroid dosage was tapered to 10 mg/d." | 2.73 | Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. ( Cid, MC; Hoffman, GS; Merkel, PA; Rahman, MU; Rendt-Zagar, KE; Salvarani, C; Stone, JH; Visvanathan, S; Weyand, CM; Xu, W, 2007) |
| "It is suggested that Horton's disease may be lacking as a stage of the infectious process in elderly patients (chronic intestinal and/or urinary infection-reactive arthritis-CA)." | 2.67 | [Etiology and treatment of temporal arteritis]. ( Gembitskiĭ, EV; Glazunov, AV; Prekhorova, EG; Zhiliaev, EV, 1994) |
| "Relapses were most common in the first year and 54% occurred in association with steroid reduction." | 2.67 | The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment. ( Hazleman, BL; Kyle, V, 1993) |
| "Three patients with signs of temporal arteritis are presented." | 2.52 | [Temporal arteritis: do not rely on the erythrocyte sedimentation rate]. ( Bernelot Moens, HJ, 2015) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 2.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| "We describe three giant cell aortitis patients who were operatively managed at our institution over the last seven years and review the recent relevant literature to highlight the specific features of the disease and the salient points of management in relation to the cardiac surgeon." | 2.46 | Aortic complications of giant cell arteritis: a diagnostic and management dilemma. ( Butler, N; Mundy, J; Shah, P, 2010) |
| "Polymyalgia rheumatica is treated with prednisolone." | 2.43 | [Polymyalgia rheumatica and giant-cell temporal arteritis]. ( Tereshchenko, IV, 2006) |
| "Polymyalgia rheumatica and temporal arteritis commonly present for the first time in older people." | 2.42 | Polymyalgia rheumatica and temporal arteritis: evidence and guidelines for diagnosis and management in older people. ( Cassidy, T; Frearson, R; Newton, J, 2003) |
| "Temporal arteritis is not considered to be a life-threatening disorder, however, visual disturbance, the most serious complication, may appear in those with affection of the ophthalmic artery, resulting in blindness in approximately 26% of the untreated cases." | 2.39 | [Temporal arteritis]. ( Katoh, M, 1994) |
| "Temporal arteritis is an insidious disease which, if not recognized and treated with high-dosage oral prednisone or intravenous prednisolone, can result in unilateral or even total blindness due to anterior ischemic optic neuropathy (AION) or closure of the central artery of the retina." | 2.38 | Diagnosis and management of temporal arteritis: a review and case report. ( Gelvin, J; Grosvenor, T; Malinovsky, V; Tonekaboni, K, 1993) |
| "Two cases of giant cell arteritis affecting the breast are described and 11 previously described cases are reviewed." | 2.38 | Giant cell arteritis (temporal arteritis) affecting the breast: report of two cases and review of published reports. ( Guindi, M; Hill, DP; McKendry, RJ, 1990) |
| "We report a case of temporal arteritis associated with anicteric cholestasis." | 2.38 | A case of temporal arteritis with intrahepatic arterial involvement. ( Kettani, S; Rohmer, V; Rousselet, MC; Saint-Andre, JP, 1989) |
| "The relationship of this disease with temporal arteritis is discussed, and I consider both syndromes have a pathological basis of generalised giant cell arteritis." | 2.35 | Giant cell arteritis in general practice. ( Rhodes, DJ, 1976) |
| "Prednisolone was started for granulocyte colony-stimulating factor (G-CSF)-induced aortitis, and symptoms and elevated serum inflammatory markers resolved rapidly, allowing early discontinuation of prednisolone." | 1.91 | Granulocyte colony-stimulating factor-induced aortitis with temporal arteritis and monoarthritis. ( Homma, Y; Honda, Y; Iida, K, 2023) |
| "Giant cell arteritis is a large vessel vasculitis of the arteries in the head and neck." | 1.72 | Tocilizumab for relapsing and remitting giant cell arteritis: a case series. ( Kaul, A; Saha, P; Sofat, N; Srikantharajah, D, 2022) |
| "To investigate the relationship between real life glucocorticoid (GC) dosing and relapse rates in patients with new onset GCA in a single centre." | 1.72 | Glucocorticoid dosing and relapses in giant cell arteritis-a single centre cohort study. ( Aringer, M; Felten, L; Leuchten, N, 2022) |
| "Diagnosis of temporal arteritis was made and linked with syndrome of inappropriate antidiuretic hormone secretion, which appears to be a rare association with few instances on record." | 1.62 | Atypical presentation of giant cell arteritis associated with SIADH: a rare association. ( Asalieh, H; Jonny, S; Tariq, S, 2021) |
| "Unlike vision loss, ptosis and diplopia are considered to be reversible and responsive to treatment." | 1.62 | Giant Cell Arteritis Presenting with Ptosis and Diplopia. ( Hasegawa, H; Hiraoka, D; Horie, K; Ishizaki, J; Matsumoto, T; Suemori, K; Takenaka, K, 2021) |
| "We report a case of superinfection of liver cysts caused by Candida albicans and Staphylococcus lugdunensis in a patient with autosomal dominant polycystic kidney disease." | 1.56 | Candida albicans and Staphylococcus lugdunensis superinfection of liver cysts in a patient with autosomal dominant polycystic kidney disease under prednisolone treatment. ( Hiramatsu, R; Iijima, T; Inui, K; Mizuno, H; Sawa, N; Suwabe, T; Takaichi, K; Ubara, Y; Yamanouchi, M, 2020) |
| "Prednisolone was initiated with clinical and analytical improvement." | 1.56 | Boundaries of a systemic disease: a protean presentation of giant cell arteritis. ( Brotas, V; Camara, L; Mesquita, A; Patrício, C, 2020) |
| "Scalp necrosis is a rare, potentially life-threatening complication of giant cell arteritis." | 1.51 | Scalp ulceration: a rare manifestation of giant cell arteritis. ( Baker, G; Kerr, O; McDonald, L, 2019) |
| "A 71-year-old female with advanced endometrial cancer was treated with pegfilgrastim." | 1.51 | Large-vessel vasculitis associated with PEGylated granulocyte-colony stimulating factor. ( Hirata, S; Mokuda, S; Sugiyama, E; Yoshida, Y; Yukawa, K, 2019) |
| "We herein report a case of acute myeloid leukemia (AML) complicated by GCA that manifested during chemotherapy for AML." | 1.43 | Acute Myeloid Leukemia Complicated by Giant Cell Arteritis. ( Akasaka, H; Itoh, K; Itoh, T; Izumi, M; Kodaka, T; Nohda, Y; Sakane, E; Takahashi, T; Tsuji, G; Tsunemine, H; Umeda, R, 2016) |
| "We herein describe a rare case of temporal arteritis associated with hypertrophic pachymeningitis." | 1.43 | Hypertrophic Pachymeningitis as a Potential Cause of Headache Associated with Temporal Arteritis. ( Hideyama, T; Maekawa, R; Matsuura, H; Shiio, Y; Tamura, K; Tokushige, S, 2016) |
| "Scalp necrosis is an important sign that should prompt those approached by these patients to consider GCA." | 1.42 | Forehead necrosis, one of the many facades of giant cell arteritis. ( Palmer, VE; Vusirikala, B; Young-Zvandasara, T, 2015) |
| "We thought the mechanism of this cerebral infarction as artery to artery embolization or intracranial arteritis." | 1.42 | [Medial longitudinal fasciculus (MLF) syndrome in a patient with giant cell arteritis]. ( Hamaguchi, H; Kanda, F; Kowa, H; Sekiguchi, K; Toda, T; Uenaka, T, 2015) |
| "We report two cases of atypical temporal arteritis." | 1.38 | [The diagnostic risk of overlooking temporal arteritis]. ( Januschowski, K; Wilhelm, H, 2012) |
| "Giant cell arteritis with arteritic anterior ischemic optic neuropathy has rarely been diagnosed in Taiwan." | 1.36 | Giant cell (Temporal) arteritis with anterior ischemic optic neuropathy: a biopsy-proven case in Taiwan. ( Cheng, CK; Huang, KH; Lee, CC; Peng, PH; Wu, TE, 2010) |
| "Polymyalgia rheumatica is a clinical diagnosis without a 'gold standard' serological or histological test and there are other conditions that may mimic PMR." | 1.35 | Polymyalgia rheumatica and its links with giant cell arteritis. ( Charlton, R, 2008) |
| "Giant cell arteritis (GCA), also called temporal arteritis, is a systemic inflammatory vasculitis of unknown etiology that affects medium- and large-sized arteries." | 1.35 | Hyperostosis frontalis interna in a patient with giant cell arteritis. ( Butun, B; Gurbuz, U; Illeez, O; Kocabas, H; Melikoglu, MA; Ozbudak, IH; Sezer, I, 2008) |
| "Although temporal arteritis is a rare cause of ophthalmoplegia in the elderly patients, swift diagnosis and treatment is necessary to avoid blindness." | 1.34 | [Temporal arteritis presenting with headache and abducens nerve palsy. Report of a case]. ( Arai, M; Katsumata, R, 2007) |
| "Epidural lipomatosis is a rare but severe complication of long-term corticoid treatment." | 1.33 | [Extradural lipomatosis after long-term treatment with steroids]. ( Burkhardt, N; Hamann, GF, 2006) |
| "However, recurrences are frequent and corticosteroid requirements are highly variable among patients." | 1.33 | Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis. ( Cid, MC; Elkin, M; García-Martínez, A; Grau, JM; Hernández-Rodríguez, J; Hoffman, MP; Kleinman, HK; Pla-Campo, M; Sánchez, M; Segarra, M; Vilardell, C, 2006) |
| "Visual complications of temporal arteritis are frequent and serious." | 1.33 | [Iatrogenic central serous chorioretinopathy during glucocorticoid therapy for temporal arteritis]. ( Chauveheid, MP; Doan, S; Lidove, O; Papo, T; Steichen, O, 2006) |
| "Giant cell arteritis is a chronic granulomatous inflammation of unknown aetiology involving large and medium size arteries in the elderly." | 1.31 | Giant cell arteritis causing bilateral sequential anterior ischaemic optic neuropathy--a case report. ( Goh, KY; Lim, TH, 2000) |
| " Corticosteroid toxicity is a major problem, either because of inappropriate dosage or prolonged disease." | 1.31 | Polymyalgia rheumatica and giant cell arteritis. Avoiding management traps. ( de Jager, JP, 2001) |
| "Polymyalgia rheumatica is often diagnosed and treated in general practice." | 1.31 | [Polymyalgia rheumatica in general practice]. ( Bratland, B, 2001) |
| "To determine the incidence of temporal arteritis (TA) in a population in Vest Agder County in southern Norway and to examine the frequency of disease related clinical findings in these patients." | 1.31 | Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. ( Bie, RB; Haugeberg, G; Paulsen, PQ, 2000) |
| "Giant cell arteritis is a serious condition, requiring immediate treatment." | 1.30 | Giant cell arteritis--a case report. ( Franklin, CD; Nixon, PP; Payne, M, 1997) |
| "A 61-year-old man developed hypersensitivity pneumonitis and skin rash in close association with taking co-proxamol." | 1.30 | Hypersensitivity pneumonitis associated with co-proxamol (paracetamol + dextropropoxyphene) therapy. ( Crompton, GK; Matusiewicz, SP; Wallace, WA, 1999) |
| " The three laboratory investigations were, therefore, of limited value in confirming relapses of PMR/GCA during prednisolone treatment, but alpha 1-ACT may be useful as an indicator of underlying disease activity and hence as a guide to the speed that the prednisolone dosage should be reduced." | 1.29 | Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. ( Calvin, J; Hazleman, BL; Pountain, GD, 1994) |
| " Clinical response and outcome, as well as prednisone dosage and adverse effects, were recorded throughout the followup period." | 1.29 | Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. ( Friedlander, Y; Nesher, G; Sonnenblick, M, 1994) |
| "Patients with arteritis (n = 106) were studied and divided into five groups." | 1.29 | The diagnosis and management of arteritis. ( Cawthorn, SJ; Giddings, AE; Karanjia, ND, 1993) |
| "Intestinal perforation is a rare complication of TA." | 1.29 | Intestinal perforation in temporal arteritis, associated with paroxysmal nocturnal hemoglobinuria. ( Nakao, K; Nishibe, K; Shinoda, E; Takahashi, T; Takeuchi, E; Taniguchi, Y; Tsuyuoka, R, 1996) |
| "Two patients with temporal arteritis who presented with pleural effusion are reported." | 1.28 | Pleural effusion as manifestation of temporal arteritis. ( Aranda, I; Martín, C; Padilla, I; Romero, S; Rosas, J; Vela, P, 1992) |
| "Cranial Arteritis (Giant Cell Arteritis) is a clinical diagnosis supported by a raised erythrocyte sedimentation rate (ESR) and if required confirmed by a temporal artery biopsy." | 1.28 | Brainstem vascular accidents and cranial arteritis. ( Dick, AD; Johnson, N; Millar, A, 1991) |
| "The symptoms of Horton's disease were revealed in 19 patients (32." | 1.28 | [The clinical manifestations of polymyalgia rheumatica]. ( Bunchuk, NV; Rytikova, MI, 1991) |
| "Temporal arteritis (giant cell arteritis) is a disease of protean manifestation." | 1.28 | Temporal arteritis presenting as a submandibular swelling. ( Porter, MJ, 1990) |
| "Ocular complications occurring in temporal arteritis are of different severities." | 1.28 | [Eye manifestations of Horton's disease]. ( Antoine, C; Koenig, F; Maugery, J; Michel, D; Rousset, H, 1989) |
| "We describe a series of 7 patients with temporal arteritis (TA), 5 of whom had undoubted TA and 2 almost certainly had TA." | 1.28 | Temporal arteritis. The Indian scene. ( Desai, MC; Vas, CJ, 1989) |
| "A patient with biopsy proven temporal arteritis/polymyalgia rheumatica and erosive rheumatoid arthritis is presented." | 1.27 | Coexistence of temporal arteritis/polymyalgia rheumatica and rheumatoid arthritis. ( Husby, G; Omdal, R, 1984) |
| " To assess the influence on the course of these diseases of the clinical symptoms at initial presentation and of the starting dosage of corticosteroid (CS) treatment the data for 210 patients, who were diagnosed as having PMR or TA from 1976 to 1986 and were followed up closely, were reviewed." | 1.27 | Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). ( Cohen de Lara, A; Delecoeuillerie, G; Joly, P; Paolaggi, JB, 1988) |
| "An unusual case of temporal arteritis presenting with sensorineural hearing loss is presented." | 1.27 | Steroid-responsive hearing loss in temporal arteritis. ( Kramer, MR; Nesher, G; Sonnenblick, M, 1988) |
| "The sensation of facial swelling in temporal arteritis may be an important predictor of the development of visual disturbance." | 1.27 | The sensation of facial swelling in temporal arteritis: a predictor for the development of visual disturbance. ( Friedman, B; Friedman, G, 1986) |
| "Early diagnosis of polymyalgia rheumatica is often difficult." | 1.27 | Polymyalgia rheumatica. ( Sewell, JR, 1986) |
| " Most of the flare-ups occurred during the first year of therapy and in 55% of the patients on a prednisolone dosage of 5 mg or less." | 1.27 | Long-term corticosteroid treatment in giant cell arteritis. ( Andersson, R; Bengtsson, BA; Malmvall, BE, 1986) |
| "In the literature 7 cases of temporal arteritis accompanied by ocular hypotony have been reported." | 1.26 | Acute ocular hypotony. A rare complication of temporal arteritis. ( Bardach, H; Radda, TM; Riss, B, 1981) |
| "Polymyalgia rheumatica was the most common symptom of flare-up or relapse, regardless of the clinical picture at the time of diagnosis." | 1.26 | Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. ( Bengtsson, BA; Malmvall, BE, 1981) |
| " Steroid therapy should not only be introduced rapidly at appropriate dosage levels as soon as the diagnosis is made but should not be reduced or discontinued prematurely." | 1.25 | Visual complications of polymyalgia rheumatica (polymyalgia arteritica). ( Hart, FD, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 85 (25.91) | 18.7374 |
| 1990's | 68 (20.73) | 18.2507 |
| 2000's | 71 (21.65) | 29.6817 |
| 2010's | 72 (21.95) | 24.3611 |
| 2020's | 32 (9.76) | 2.80 |
| Authors | Studies |
|---|---|
| Felten, L | 1 |
| Leuchten, N | 1 |
| Aringer, M | 1 |
| Manzo, C | 1 |
| Milchert, M | 1 |
| Isetta, M | 1 |
| Natale, M | 1 |
| Castagna, A | 1 |
| Frølund, LL | 2 |
| Våben, C | 2 |
| Dam, M | 2 |
| Kjær, SG | 2 |
| Nielsen, BD | 4 |
| Østgård, RD | 2 |
| Keller, KK | 3 |
| Therkildsen, P | 1 |
| de Thurah, A | 1 |
| Hansen, IT | 2 |
| Eldrup, N | 1 |
| Nørgaard, M | 1 |
| Hauge, EM | 2 |
| Tariq, S | 1 |
| Jonny, S | 1 |
| Asalieh, H | 1 |
| Kasahara, A | 1 |
| Kida, T | 1 |
| Hirano, A | 1 |
| Omura, S | 1 |
| Sofue, H | 1 |
| Sakashita, A | 1 |
| Sagawa, T | 1 |
| Asano, M | 1 |
| Fukui, M | 1 |
| Wada, M | 1 |
| Kohno, M | 1 |
| Kawahito, Y | 1 |
| Das, S | 1 |
| Goswami, RP | 1 |
| Sinha, D | 1 |
| Ghosal, A | 1 |
| Datta, A | 1 |
| Sarkar, S | 1 |
| Kramarič, J | 1 |
| Ješe, R | 2 |
| Tomšič, M | 2 |
| Rotar, Ž | 1 |
| Hočevar, A | 2 |
| Marsman, DE | 1 |
| Bolhuis, TE | 1 |
| den Broeder, N | 1 |
| den Broeder, AA | 1 |
| van der Maas, A | 2 |
| Lundberg, IE | 1 |
| Sharma, A | 1 |
| Turesson, C | 1 |
| Mohammad, AJ | 1 |
| Saha, P | 1 |
| Srikantharajah, D | 1 |
| Kaul, A | 1 |
| Sofat, N | 1 |
| Matsumoto, K | 1 |
| Suzuki, K | 1 |
| Yoshida, H | 1 |
| Magi, M | 1 |
| Matsumoto, Y | 1 |
| Noguchi-Sasaki, M | 1 |
| Yoshimoto, K | 1 |
| Takeuchi, T | 1 |
| Kaneko, Y | 1 |
| Vijayaraghavan, N | 1 |
| Martin, J | 1 |
| Jayawickrama, W | 1 |
| Otome, O | 1 |
| Donskov, AO | 1 |
| Mackie, SL | 3 |
| Toro-Gutiérrez, CE | 1 |
| Hemmig, AK | 1 |
| Gheita, T | 1 |
| Douglas, KMJ | 1 |
| Conway, R | 2 |
| Rezus, E | 1 |
| Dasgupta, B | 9 |
| Monti, S | 2 |
| Matteson, EL | 2 |
| Sattui, SE | 1 |
| Matza, M | 1 |
| Ocampo, V | 1 |
| Gromova, M | 1 |
| Grainger, R | 1 |
| Bran, A | 1 |
| Appenzeller, S | 1 |
| Goecke, A | 1 |
| Colman, N | 1 |
| Keen, HI | 1 |
| Kuwana, M | 1 |
| Gupta, L | 1 |
| Salim, B | 1 |
| Harifi, G | 1 |
| Erraoui, M | 1 |
| Ziade, N | 1 |
| Al-Ani, NA | 1 |
| Ajibade, A | 1 |
| Knitza, J | 1 |
| Frølund, L | 1 |
| Yates, M | 2 |
| Pimentel-Quiroz, VR | 1 |
| Lyrio, AM | 1 |
| Sandovici, M | 2 |
| Van der Geest, KSM | 2 |
| Helliwell, T | 2 |
| Brouwer, E | 2 |
| Dejaco, C | 1 |
| Iida, K | 1 |
| Honda, Y | 1 |
| Homma, Y | 1 |
| Eriksson, P | 1 |
| Skoglund, O | 1 |
| Hemgren, C | 1 |
| Sjöwall, C | 1 |
| Yukawa, K | 1 |
| Mokuda, S | 1 |
| Yoshida, Y | 2 |
| Hirata, S | 1 |
| Sugiyama, E | 1 |
| Miler, E | 1 |
| Stapleton, PP | 2 |
| Mapplebeck, S | 2 |
| Mackerness, C | 2 |
| Gayford, D | 2 |
| Aung, T | 1 |
| Wilson, L | 1 |
| Schofield, P | 2 |
| McDonald, L | 1 |
| Baker, G | 1 |
| Kerr, O | 1 |
| Borresen, SW | 2 |
| Thorgrimsen, TB | 2 |
| Jensen, B | 2 |
| Hilsted, L | 2 |
| Bartels, EM | 2 |
| Feldt-Rasmussen, U | 2 |
| Locht, H | 2 |
| Mesquita, A | 1 |
| Camara, L | 1 |
| Patrício, C | 1 |
| Brotas, V | 1 |
| Ponte, C | 2 |
| Serafim, AS | 1 |
| Fernandes, E | 1 |
| Lee, E | 1 |
| Singh, S | 2 |
| Piper, J | 1 |
| Hutchings, A | 1 |
| McNally, E | 1 |
| Diamantopoulos, AP | 2 |
| Schmidt, WA | 3 |
| Luqmani, RA | 1 |
| Iijima, T | 1 |
| Suwabe, T | 1 |
| Inui, K | 1 |
| Mizuno, H | 1 |
| Hiramatsu, R | 1 |
| Yamanouchi, M | 1 |
| Sawa, N | 1 |
| Takaichi, K | 1 |
| Ubara, Y | 1 |
| Ambrožič, A | 1 |
| Markez, S | 1 |
| Pfeil, A | 1 |
| Franz, M | 1 |
| Wolf, G | 1 |
| Freesmeyer, M | 1 |
| Onyema, MC | 1 |
| Kearney, J | 1 |
| Dimitriadis, GK | 1 |
| Hiraoka, D | 1 |
| Ishizaki, J | 1 |
| Horie, K | 1 |
| Matsumoto, T | 1 |
| Suemori, K | 1 |
| Takenaka, K | 1 |
| Hasegawa, H | 1 |
| Emamifar, A | 2 |
| Ellingsen, T | 1 |
| Hermann, AP | 2 |
| Hess, S | 2 |
| Gerke, O | 2 |
| Ahangarani Farahani, Z | 1 |
| Syrak Hansen, P | 1 |
| Jensen Hansen, IM | 1 |
| Thye-Rønn, P | 2 |
| Espitia, O | 1 |
| Agard, C | 1 |
| Schönau, V | 1 |
| Roth, J | 1 |
| Tascilar, K | 1 |
| Corte, G | 1 |
| Manger, B | 1 |
| Rech, J | 1 |
| Schmidt, D | 1 |
| Cavallaro, A | 1 |
| Uder, M | 1 |
| Crescentini, F | 1 |
| Boiardi, L | 3 |
| Casali, M | 1 |
| Spaggiari, L | 1 |
| Galli, E | 1 |
| Kuwert, T | 1 |
| Versari, A | 1 |
| Salvarani, C | 5 |
| Schett, G | 1 |
| Muratore, F | 2 |
| Cunha, RN | 1 |
| Duarte-Monteiro, AM | 1 |
| Tenazinha, C | 1 |
| Khmelinskii, N | 1 |
| Zuckerman, R | 1 |
| Patel, M | 1 |
| Alpert, DR | 1 |
| Larsen, JM | 1 |
| Aabenhus, K | 1 |
| Shikino, K | 1 |
| Yamashita, S | 1 |
| Ikusaka, M | 1 |
| Laustrup, H | 1 |
| Hansen, PS | 1 |
| Marcussen, N | 1 |
| Svendstrup, F | 1 |
| Gildberg-Mortensen, R | 1 |
| Bang, JC | 1 |
| Farahani, ZA | 1 |
| Chrysidis, S | 1 |
| Toftegaard, P | 1 |
| Andreasen, RA | 1 |
| le Greves, S | 1 |
| Andersen, HR | 1 |
| Olsen, RN | 1 |
| Hansen, IMJ | 1 |
| Samia-Aly, E | 1 |
| Madge, S | 1 |
| Raine, C | 1 |
| Merinopoulos, D | 1 |
| Maw, WW | 1 |
| Achilleos, K | 1 |
| Sajawal, S | 1 |
| Hillmen, P | 1 |
| McGonagle, D | 1 |
| Kobayashi, M | 1 |
| Shimojo, H | 1 |
| Shingu, K | 1 |
| Harada, M | 1 |
| Kanno, H | 1 |
| Schirmer, M | 1 |
| O'Neill, L | 1 |
| Gallagher, P | 1 |
| McCarthy, GM | 1 |
| Murphy, CC | 1 |
| Veale, DJ | 1 |
| Fearon, U | 1 |
| Molloy, ES | 1 |
| Power, SP | 1 |
| O'Mahony, D | 1 |
| Tengesdal, S | 1 |
| Myklebust, G | 3 |
| Matsuoka, H | 1 |
| Oguro, E | 1 |
| Murata, A | 1 |
| Kuzuya, K | 1 |
| Okita, Y | 1 |
| Teshigawara, S | 1 |
| Yoshimura, M | 1 |
| Isoda, K | 2 |
| Harada, Y | 1 |
| Kaminou, T | 1 |
| Ohshima, S | 1 |
| Saeki, Y | 1 |
| Sagar, D | 1 |
| Sagar, AS | 1 |
| Soussi, S | 1 |
| Dwyer, KM | 1 |
| Tai, A | 1 |
| Smith, P | 1 |
| Buchbinder, R | 1 |
| Wu, J | 1 |
| Keeley, A | 1 |
| Mallen, C | 1 |
| Morgan, AW | 1 |
| Pujades-Rodriguez, M | 1 |
| van Sleen, Y | 1 |
| Boots, AMH | 1 |
| Abdulahad, WH | 1 |
| Bijzet, J | 1 |
| Alfuraih, AM | 1 |
| Tan, AL | 1 |
| O'Connor, P | 1 |
| Emery, P | 1 |
| Mackie, S | 1 |
| Wakefield, RJ | 1 |
| Akın, S | 1 |
| Bahat, G | 1 |
| Tufan, F | 1 |
| Saka, B | 1 |
| Oztop, N | 1 |
| Erten, N | 1 |
| Karan, MA | 1 |
| Loke, YK | 1 |
| Watts, RA | 1 |
| MacGregor, AJ | 1 |
| Jodo, S | 1 |
| Hisada, R | 1 |
| McAlinden, C | 2 |
| Ioannidis, P | 1 |
| Roberts, S | 1 |
| Skiadaresi, E | 2 |
| Parra, J | 1 |
| Domingues, J | 1 |
| Sargento-Freitas, J | 1 |
| Santana, I | 1 |
| Kong, KK | 1 |
| Mackinnon, AD | 1 |
| Bridges, LR | 1 |
| Cloud, GC | 1 |
| Banerjee, PJ | 1 |
| Petrou, P | 1 |
| Plant, GT | 1 |
| Petri, H | 1 |
| Nevitt, A | 1 |
| Sarsour, K | 3 |
| Napalkov, P | 3 |
| Collinson, N | 3 |
| Hittinger, M | 1 |
| Berlis, A | 1 |
| Pfadenhauer, K | 1 |
| Larsen, CC | 1 |
| Schifter, S | 1 |
| Bonnema, SJ | 1 |
| Tucker, LJ | 1 |
| Mankia, KS | 1 |
| Magliano, M | 1 |
| Uenaka, T | 1 |
| Hamaguchi, H | 1 |
| Sekiguchi, K | 1 |
| Kowa, H | 1 |
| Kanda, F | 1 |
| Toda, T | 1 |
| Palmer, VE | 1 |
| Young-Zvandasara, T | 1 |
| Vusirikala, B | 1 |
| Bernelot Moens, HJ | 1 |
| Labarca, C | 1 |
| Koster, MJ | 1 |
| Crowson, CS | 1 |
| Makol, A | 1 |
| Ytterberg, SR | 1 |
| Warrington, KJ | 2 |
| Fior, A | 1 |
| Barreto, P | 1 |
| Thanos, A | 1 |
| Esmaili, DD | 1 |
| Eliott, D | 1 |
| Tsunemine, H | 1 |
| Umeda, R | 1 |
| Nohda, Y | 1 |
| Sakane, E | 1 |
| Akasaka, H | 1 |
| Itoh, K | 1 |
| Izumi, M | 1 |
| Tsuji, G | 1 |
| Kodaka, T | 1 |
| Itoh, T | 1 |
| Takahashi, T | 2 |
| Akram, Q | 1 |
| Chinoy, H | 1 |
| Tokushige, S | 1 |
| Matsuura, H | 1 |
| Hideyama, T | 1 |
| Tamura, K | 1 |
| Maekawa, R | 1 |
| Shiio, Y | 1 |
| Villiger, PM | 1 |
| Adler, S | 1 |
| Kuchen, S | 1 |
| Wermelinger, F | 1 |
| Dan, D | 1 |
| Fiege, V | 1 |
| Bütikofer, L | 1 |
| Seitz, M | 1 |
| Reichenbach, S | 1 |
| Cheema, MR | 1 |
| Ismaeel, SM | 1 |
| Takaki, M | 1 |
| Inozume, T | 1 |
| Sano, S | 1 |
| Mitsui, H | 1 |
| Kawamura, T | 1 |
| Shimada, S | 1 |
| Gehlen, M | 1 |
| Schwarz-Eywill, M | 1 |
| Schäfer, N | 1 |
| Pfeiffer, A | 1 |
| Bösenberg, H | 1 |
| Maier, A | 1 |
| Hinz, C | 1 |
| Tan, BL | 1 |
| Liu, JJ | 1 |
| Yong, TY | 1 |
| Tan, CC | 1 |
| Li, JY | 1 |
| Faurschou, M | 1 |
| Ahlström, MG | 1 |
| Lindhardsen, J | 1 |
| Obel, N | 1 |
| Baslund, B | 1 |
| Hume, ME | 1 |
| Fernandes, PM | 1 |
| MacLean, K | 1 |
| McRorie, E | 1 |
| Davenport, R | 1 |
| Wilson, JC | 2 |
| Tuckwell, K | 2 |
| Musselman, D | 2 |
| Klearman, M | 2 |
| Jick, SS | 2 |
| Stone, JH | 3 |
| Meier, CR | 2 |
| Arai, T | 1 |
| Tanaka, R | 1 |
| Kaburaki, T | 1 |
| Liozon, E | 1 |
| Gondran, G | 1 |
| Ly, K | 1 |
| Loustaud, V | 1 |
| Vidal, E | 1 |
| Takekawa, H | 1 |
| Daimon, Y | 1 |
| Takashima, R | 1 |
| Aiba, S | 1 |
| Tanaka, H | 1 |
| Hirata, K | 1 |
| Charlton, R | 1 |
| Borg, FA | 1 |
| Saidha, S | 1 |
| Mok, TH | 1 |
| Butler, M | 1 |
| Keohane, C | 1 |
| Harrington, H | 1 |
| van Rooijen, JM | 1 |
| Jagt, T | 1 |
| Vastenburg, G | 1 |
| van der Kleij, FG | 1 |
| Hensor, EM | 1 |
| Haugeberg, G | 3 |
| Bhakta, B | 1 |
| Pease, CT | 1 |
| Watanabe, R | 1 |
| Nakaya, I | 1 |
| Kudo, H | 1 |
| Yahata, M | 1 |
| Sakuma, T | 1 |
| Soma, J | 1 |
| Venhuizen, A | 1 |
| Tekstra, J | 1 |
| Cullen, JF | 5 |
| Chan, BM | 1 |
| Wong, CF | 1 |
| Chew, WC | 1 |
| Ghaffar, SA | 1 |
| Todd, PM | 1 |
| Brick, KE | 1 |
| Cook-Norris, RH | 1 |
| Wetter, DA | 1 |
| Cheng, CK | 1 |
| Lee, CC | 1 |
| Huang, KH | 1 |
| Wu, TE | 1 |
| Peng, PH | 1 |
| Fitzgerald, AJ | 1 |
| Ironside, JW | 1 |
| Summers, DM | 1 |
| Dennis, MS | 1 |
| McRorie, ER | 1 |
| Butler, N | 1 |
| Mundy, J | 1 |
| Shah, P | 1 |
| Balakrishnan, C | 1 |
| Mangat, G | 1 |
| Samant, R | 1 |
| Bambani, M | 1 |
| Kalke, S | 1 |
| Joshi, VR | 1 |
| Kraemer, M | 1 |
| Metz, A | 1 |
| Herold, M | 1 |
| Venker, C | 1 |
| Berlit, P | 1 |
| Mammatas, LH | 1 |
| Stam, F | 1 |
| Baskar, S | 1 |
| Etti, R | 1 |
| Kitas, G | 1 |
| Klocke, R | 1 |
| Oka, K | 1 |
| Suzuki, A | 1 |
| Hakamata, Y | 1 |
| Hirose, T | 1 |
| Koumura, A | 1 |
| Ikegami, R | 1 |
| Obe, T | 1 |
| Miyazaki, S | 1 |
| Aonuma, H | 1 |
| Fujii, T | 1 |
| Suzuki, T | 1 |
| Ishizuka, T | 1 |
| Lee, S | 1 |
| Childerhouse, A | 1 |
| Moss, K | 1 |
| Papadopoulos, E | 1 |
| Szurman, P | 1 |
| Haberl, GC | 1 |
| Tudor, SE | 1 |
| Petermeier, K | 1 |
| Adizie, T | 1 |
| Besada, E | 1 |
| Nossent, JC | 1 |
| Barraclough, K | 1 |
| Mallen, CD | 1 |
| Hider, SL | 1 |
| Nair, JR | 1 |
| Somauroo, JD | 1 |
| Over, KE | 1 |
| Moll, R | 1 |
| Hameed, B | 1 |
| Januschowski, K | 1 |
| Wilhelm, H | 1 |
| Tweddle, EA | 1 |
| Gilligan, AK | 1 |
| Fogarty, PW | 1 |
| Schnabel, A | 1 |
| Ostör, AJ | 1 |
| Hazleman, BL | 6 |
| Gabler, B | 1 |
| Sandstad, E | 1 |
| Aksnes, H | 1 |
| Sund, S | 1 |
| Reinholt, FP | 1 |
| Matsushima, M | 1 |
| Yamanaka, K | 1 |
| Mori, H | 1 |
| Murakami, T | 2 |
| Hakamada, A | 1 |
| Mizutani, H | 1 |
| Förderreuther, S | 1 |
| Ihrler, S | 1 |
| Küchle, CC | 1 |
| Valstar, MH | 1 |
| Terpstra, WF | 1 |
| de Jong, RS | 1 |
| Frearson, R | 1 |
| Cassidy, T | 1 |
| Newton, J | 1 |
| Bunch, TJ | 1 |
| Welsh, GA | 1 |
| Miller, DV | 1 |
| Santhi, VS | 1 |
| RIEDERER, J | 1 |
| BENGE, JH | 1 |
| FRELICK, RW | 1 |
| FREEDLAND, ME | 1 |
| FORSSMAN, O | 1 |
| KORSGREN, M | 1 |
| NORDH, B | 1 |
| PAULSEN, F | 1 |
| RUSSELL, RW | 2 |
| EARL, CJ | 1 |
| DONNELLY, P | 1 |
| Garcia-Porrua, C | 1 |
| Pego-Reigosa, R | 1 |
| Armesto, V | 1 |
| Gonzalez-Gay, MA | 1 |
| Chan, CM | 1 |
| Chuah, KL | 1 |
| Gran, JT | 3 |
| Bratland, B | 2 |
| Kitagawa, Y | 2 |
| Zborowska, B | 1 |
| Ell, J | 1 |
| McGhee-Collett, M | 1 |
| Scolyer, R | 1 |
| McCluskey, PJ | 1 |
| García-Martínez, A | 2 |
| Hernández-Rodríguez, J | 2 |
| Grau, JM | 2 |
| Cid, MC | 3 |
| de Leeuw, K | 1 |
| Bijl, M | 1 |
| Jager, PL | 1 |
| Kametsu, Y | 1 |
| Bhatia, A | 1 |
| Ell, PJ | 1 |
| Edwards, JC | 1 |
| Bevis, T | 1 |
| Ratnakaram, R | 1 |
| Smith, MF | 1 |
| Bhatti, MT | 1 |
| Azhar, SS | 1 |
| Tang, RA | 1 |
| Dorotheo, EU | 1 |
| Morris, OC | 1 |
| Lockie, P | 1 |
| Roddy, E | 1 |
| Summers, G | 1 |
| Chaudry, Z | 1 |
| Bateman, R | 1 |
| Mecklenburg, I | 1 |
| Brumberger, V | 1 |
| Burchardi, C | 1 |
| Rademacher, A | 1 |
| Pfeifer, KJ | 1 |
| Folwaczny, C | 1 |
| Hoffman, MP | 1 |
| Segarra, M | 1 |
| Elkin, M | 1 |
| Sánchez, M | 1 |
| Vilardell, C | 1 |
| Pla-Campo, M | 1 |
| Kleinman, HK | 1 |
| Subrahmanyan, P | 1 |
| Serradell, S | 1 |
| Laiz, A | 1 |
| Castaño, C | 1 |
| de Llobet, JM | 1 |
| McKillop, E | 1 |
| Tejwani, D | 1 |
| Weir, C | 1 |
| Jay, J | 1 |
| Okun, H | 1 |
| Imai, N | 1 |
| Konishi, T | 1 |
| Suzuki, Y | 1 |
| Serizawa, M | 1 |
| Okabe, T | 1 |
| Steichen, O | 1 |
| Chauveheid, MP | 1 |
| Lidove, O | 1 |
| Doan, S | 1 |
| Papo, T | 1 |
| Kuttikat, A | 1 |
| Joshi, A | 1 |
| Saeed, I | 1 |
| Chakravarty, K | 1 |
| Tereshchenko, IV | 1 |
| Burkhardt, N | 1 |
| Hamann, GF | 1 |
| Durkin, SR | 1 |
| Athanasiov, PA | 1 |
| Crompton, JL | 2 |
| Karagiannis, A | 1 |
| Mathiopoulou, L | 1 |
| Tziomalos, K | 1 |
| Kontotasios, K | 1 |
| Skaperdas, A | 1 |
| Florentin, M | 1 |
| Amplianitis, IK | 1 |
| Athyros, VG | 1 |
| Hoffman, GS | 2 |
| Rendt-Zagar, KE | 1 |
| Merkel, PA | 1 |
| Weyand, CM | 1 |
| Xu, W | 1 |
| Visvanathan, S | 1 |
| Rahman, MU | 1 |
| Yu-Wai-Man, P | 1 |
| Dayan, MR | 2 |
| Arai, M | 1 |
| Katsumata, R | 1 |
| Arashvand, K | 1 |
| Alexander, WL | 1 |
| Sano, H | 1 |
| Bley, TA | 1 |
| Markl, M | 1 |
| Schelp, M | 1 |
| Uhl, M | 1 |
| Frydrychowicz, A | 1 |
| Vaith, P | 1 |
| Peter, HH | 1 |
| Langer, M | 1 |
| Warnatz, K | 1 |
| Kocabas, H | 1 |
| Sezer, I | 1 |
| Melikoglu, MA | 1 |
| Gurbuz, U | 1 |
| Illeez, O | 1 |
| Ozbudak, IH | 1 |
| Butun, B | 1 |
| Pipitone, N | 1 |
| Hunder, GG | 1 |
| Strachan, RW | 1 |
| How, J | 1 |
| Bewsher, PD | 1 |
| Auplat, P | 1 |
| Janin-Manificat, L | 1 |
| Marchal, G | 1 |
| Besancentot, JF | 1 |
| Cortet, P | 1 |
| Kirby, J | 1 |
| Fielding, JF | 1 |
| Omdal, R | 1 |
| Husby, G | 1 |
| Chou, CT | 1 |
| Schumacher, HR | 1 |
| Thomas, TP | 1 |
| Allison, MC | 2 |
| Gallagher, PJ | 1 |
| Behn, AR | 1 |
| Perera, T | 2 |
| Myles, AB | 5 |
| Bengtsson, BA | 11 |
| Malmvall, BE | 7 |
| Mulley, GP | 1 |
| Dunker, PJ | 1 |
| Ebel, J | 1 |
| Francis, DA | 1 |
| Boddie, HG | 1 |
| Dare, B | 1 |
| Byrne, E | 1 |
| Robertson, A | 1 |
| Radda, TM | 1 |
| Bardach, H | 1 |
| Riss, B | 1 |
| Alestig, K | 1 |
| Bojs, G | 1 |
| Iwarson, S | 1 |
| Mukherjee, DK | 1 |
| Speed, CA | 1 |
| Haslock, I | 1 |
| Ferris, J | 1 |
| Lamb, R | 1 |
| Macchioni, P | 1 |
| Rossi, F | 1 |
| Tartoni, P | 1 |
| Casadei Maldini, M | 1 |
| Mancini, R | 1 |
| Beltrandi, E | 1 |
| Portioli, I | 1 |
| Fisken, RA | 1 |
| Gembitskiĭ, EV | 1 |
| Glazunov, AV | 1 |
| Zhiliaev, EV | 1 |
| Prekhorova, EG | 1 |
| Katoh, M | 1 |
| Nesher, G | 2 |
| Sonnenblick, M | 2 |
| Friedlander, Y | 1 |
| Shimamoto, Y | 1 |
| Matsunaga, C | 1 |
| Suga, K | 1 |
| Fukushima, N | 1 |
| Nomura, K | 1 |
| Yamaguchi, M | 2 |
| Karanjia, ND | 1 |
| Cawthorn, SJ | 1 |
| Giddings, AE | 1 |
| Nordborg, E | 4 |
| Hansson, T | 1 |
| Jonson, R | 1 |
| Szücs, J | 1 |
| Alberts, AR | 1 |
| Lasonde, R | 1 |
| Ackerman, KR | 1 |
| Chartash, EK | 1 |
| Susin, M | 1 |
| Furie, RA | 1 |
| Freeman, AG | 2 |
| Panayi, GS | 1 |
| Pountain, GD | 2 |
| Calvin, J | 1 |
| Khalaf, K | 1 |
| Pages, M | 1 |
| Blard, JM | 1 |
| Labauge, P | 1 |
| Grosvenor, T | 1 |
| Malinovsky, V | 1 |
| Gelvin, J | 1 |
| Tonekaboni, K | 1 |
| Keogan, MT | 1 |
| Brown, DL | 1 |
| Simon, JP | 1 |
| Vanco, G | 1 |
| Kyle, V | 4 |
| Askari, A | 1 |
| Jolobe, OM | 1 |
| Shepherd, DI | 1 |
| Gudmundsson, M | 1 |
| Bjelle, A | 1 |
| Ohta, A | 1 |
| Tsuyuoka, R | 1 |
| Shinoda, E | 1 |
| Taniguchi, Y | 1 |
| Nishibe, K | 1 |
| Takeuchi, E | 1 |
| Nakao, K | 1 |
| Lambert, M | 1 |
| Weber, A | 1 |
| Boland, B | 1 |
| De Plaen, JF | 1 |
| Donckier, J | 1 |
| Hatzis, GS | 1 |
| Aroni, KG | 1 |
| Kelekis, DA | 1 |
| Boki, KA | 1 |
| Toshima, M | 1 |
| Emori, Y | 1 |
| Matsuyama, J | 1 |
| Yoshio, T | 1 |
| Minota, S | 1 |
| Kano, S | 1 |
| Hiraga, T | 1 |
| Finlay, R | 1 |
| Nixon, PP | 1 |
| Payne, M | 1 |
| Franklin, CD | 1 |
| Johnson, H | 1 |
| Bouman, W | 1 |
| Pinner, G | 1 |
| Muzulu, SI | 1 |
| Howlett, TA | 1 |
| Nishikai, M | 1 |
| Kontoyianni, A | 1 |
| Maragou, M | 1 |
| Alvanou, E | 1 |
| Kappou, I | 1 |
| Dantis, P | 1 |
| Distler, O | 1 |
| Müller-Ladner, U | 1 |
| Glück, T | 1 |
| Kupersmith, MJ | 1 |
| Langer, R | 1 |
| Mitnick, H | 1 |
| Spiera, R | 1 |
| Spiera, H | 1 |
| Richmond, M | 1 |
| Paget, S | 1 |
| Harada, S | 1 |
| Mitsunobu, F | 1 |
| Kodama, F | 1 |
| Hosaki, Y | 1 |
| Mifune, T | 1 |
| Tsugeno, H | 1 |
| Okamoto, M | 1 |
| Yamamura, M | 1 |
| Makino, H | 1 |
| Tanizaki, Y | 1 |
| Noguchi, M | 1 |
| Tatezawa, T | 1 |
| Nakajima, S | 1 |
| Ishikawa, O | 1 |
| Solau-Gervais, E | 1 |
| Flipo, RM | 1 |
| Kleinegger, CL | 1 |
| Lilly, GE | 1 |
| Mallia, C | 1 |
| Coleiro, B | 1 |
| Crockford, M | 1 |
| Ellul, B | 1 |
| Gatenby, PA | 1 |
| Matusiewicz, SP | 1 |
| Wallace, WA | 1 |
| Crompton, GK | 1 |
| Goh, KY | 1 |
| Lim, TH | 1 |
| Bygum, A | 1 |
| Brandrup, F | 1 |
| Jensen, EC | 1 |
| Dovland, H | 1 |
| Mikkelsen, B | 1 |
| Paulsen, PQ | 1 |
| Bie, RB | 1 |
| Justo-Muradas, I | 1 |
| Pérez-Suarez, M | 1 |
| Saracibar, E | 1 |
| Sedano, E | 1 |
| Pérez-Castrillón, JL | 1 |
| Casson, RJ | 1 |
| Fleming, FK | 1 |
| Shaikh, A | 1 |
| James, B | 1 |
| Masuda, Y | 1 |
| Turlakow, A | 1 |
| Yeung, HW | 1 |
| Pui, J | 1 |
| Macapinlac, H | 1 |
| Liebovitz, E | 1 |
| Rusch, V | 1 |
| Goy, A | 1 |
| Larson, SM | 1 |
| Murgatroyd, H | 1 |
| Milne, A | 1 |
| de Jager, JP | 1 |
| Bogdanici, C | 1 |
| Uddhammar, A | 1 |
| Eriksson, AL | 1 |
| Nyström, L | 1 |
| Stenling, R | 1 |
| Rantapää-Dahlqvist, S | 1 |
| Ray-Chaudhuri, N | 1 |
| Kiné, DA | 1 |
| Tijani, SO | 1 |
| Parums, DV | 1 |
| Cartlidge, N | 1 |
| Strong, NP | 1 |
| Rhodes, DJ | 1 |
| Alexander, M | 1 |
| Kampf, D | 1 |
| Douglas, JG | 1 |
| Ford, MJ | 1 |
| Innes, JA | 1 |
| Munro, JF | 1 |
| Stursberg, W | 1 |
| Dieckmann, J | 1 |
| von Knorring, J | 1 |
| Bergström, AL | 1 |
| Olsson, LB | 1 |
| Kutti, J | 1 |
| Jonasson, F | 1 |
| Elton, RA | 1 |
| Hirsch, U | 1 |
| Sundqvist, A | 1 |
| Hart, FD | 1 |
| Jeanmaire, H | 1 |
| Alexandre, JL | 1 |
| Arnaudo, JP | 1 |
| Hesse, JY | 1 |
| Regulaire, JL | 1 |
| Wiek, J | 2 |
| Krause, M | 2 |
| Schade, M | 1 |
| Wiederholt, M | 2 |
| Hansen, LL | 2 |
| Laidlaw, DA | 2 |
| Bloom, PA | 1 |
| Williams, C | 1 |
| Easty, DL | 1 |
| Romero, S | 1 |
| Vela, P | 1 |
| Padilla, I | 1 |
| Rosas, J | 1 |
| Martín, C | 1 |
| Aranda, I | 1 |
| Mason, JC | 1 |
| Walport, MJ | 1 |
| Lundberg, I | 1 |
| Hedfors, E | 1 |
| Ridley, MG | 1 |
| Clearkin, L | 1 |
| Tost, F | 1 |
| Papirov, GS | 1 |
| Kameneva, LI | 1 |
| Dick, AD | 1 |
| Millar, A | 1 |
| Johnson, N | 1 |
| Bowman, S | 1 |
| Paice, E | 1 |
| Binder, A | 1 |
| Eliashevich, VL | 1 |
| Polkhovskiĭ, AA | 1 |
| Belousov, EA | 1 |
| Kolomoets, IuV | 1 |
| Andersson, R | 4 |
| Tengborn, L | 1 |
| Edén, S | 1 |
| Bunchuk, NV | 1 |
| Rytikova, MI | 1 |
| Ulrich, C | 2 |
| Ulrich, WD | 2 |
| Ulrich, D | 2 |
| Porter, MJ | 1 |
| Diot, E | 1 |
| Diot, P | 1 |
| Lasfargues, G | 1 |
| Renard, JP | 1 |
| Lecomte, P | 1 |
| Lemarie, E | 1 |
| Lavandier, M | 1 |
| Guilmot, JL | 1 |
| McKendry, RJ | 1 |
| Guindi, M | 1 |
| Hill, DP | 1 |
| Smith, PE | 1 |
| Hudgson, P | 1 |
| Watts, MT | 1 |
| Nelson, ME | 1 |
| Rennie, IG | 1 |
| Jensen, HS | 1 |
| Mogensen, HH | 1 |
| Mikkelsen, AG | 1 |
| McAlindon, TE | 1 |
| Ferguson, IT | 1 |
| Jawad, AS | 1 |
| Hamour, AA | 1 |
| Scott, DG | 1 |
| Koenig, F | 1 |
| Antoine, C | 1 |
| Michel, D | 1 |
| Rousset, H | 1 |
| Maugery, J | 1 |
| Desai, MC | 1 |
| Vas, CJ | 1 |
| Rousselet, MC | 1 |
| Kettani, S | 1 |
| Rohmer, V | 1 |
| Saint-Andre, JP | 1 |
| Bitaudeau, P | 1 |
| Clément, S | 1 |
| Chartier, JP | 1 |
| Papapietro, PM | 1 |
| Bonnafoux, A | 1 |
| Arnaud, M | 1 |
| Trèves, R | 1 |
| Desproges-Gotteron, R | 1 |
| Burrow, DJ | 1 |
| Iyer, PV | 1 |
| Aonuma, Y | 1 |
| Itoh, M | 1 |
| Hakamata, M | 1 |
| Endo, S | 1 |
| Ohashi, H | 1 |
| Okugawa, T | 1 |
| Yamazaki, N | 1 |
| Mallya, RK | 1 |
| Hind, CR | 1 |
| Berry, H | 1 |
| Pepys, MB | 1 |
| Biel, P | 1 |
| Vives, L | 1 |
| Tarfaya, S | 1 |
| Benamara, T | 1 |
| Guillausseau, PJ | 1 |
| Eiferman, C | 1 |
| Timsit, J | 1 |
| Bouchou, P | 1 |
| Cywiner-Golenzer, C | 1 |
| Slama, R | 1 |
| Lubetzki, J | 1 |
| Hansson, GK | 1 |
| Söderström, T | 1 |
| Jonsson, R | 1 |
| Delecoeuillerie, G | 1 |
| Joly, P | 1 |
| Cohen de Lara, A | 1 |
| Paolaggi, JB | 1 |
| Kornotzki, M | 1 |
| Kramer, MR | 1 |
| Heymans, G | 1 |
| Williame, E | 1 |
| Bunker, CB | 1 |
| Dowd, PM | 1 |
| Olsson, A | 1 |
| Compton, KW | 1 |
| Cordioli, E | 1 |
| Amurri, B | 1 |
| Barbieri, M | 1 |
| Ghirardi, R | 1 |
| Morra, G | 1 |
| Martinelli, M | 1 |
| Reilly, PA | 1 |
| Maddison, PJ | 1 |
| Friedman, G | 1 |
| Friedman, B | 1 |
| Maksimov, KA | 1 |
| Sewell, JR | 1 |
| Michotte, A | 1 |
| de Keyser, J | 1 |
| Dierckx, R | 1 |
| Impens, N | 1 |
| Solheid, C | 1 |
| Ebinger, G | 1 |
| Kadoya, S | 1 |
| Nakamura, T | 1 |
| Ito, S | 1 |
| Kwak, R | 1 |
| Achar, KN | 1 |
| Metzner, HH | 1 |
| Wätzig, V | 1 |
| Strohbusch, E | 1 |
| Gough, KR | 1 |
| Wadman, B | 1 |
| Werner, I | 1 |
| Bettelheim, H | 1 |
| Hayreh, SS | 1 |
| Watson, PG | 1 |
| Lobascher, D | 1 |
| Siegenthaler, W | 1 |
| Pchelintsev, VP | 1 |
| Horven, I | 1 |
| Kaiser, H | 1 |
| Miller, JP | 1 |
| Wagner, A | 1 |
| Dillmann, G | 1 |
| Conradi, S | 1 |
| Meadows, SP | 1 |
| Morton, EV | 1 |
| Barolin, GS | 1 |
| Chlud, K | 1 |
| Smith, WH | 1 |
| Billings, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Validation d'un Algorithme Diagnostique de l'artérite Temporale Giganto-cellulaire basé Sur l'échographie-doppler Couleur Des artères Temporales Superficielles et Des Axes Cervico-encéphaliques[NCT02703922] | 168 participants (Actual) | Interventional | 2016-08-29 | Completed | |||
| CORON-ACT - a Multicenter, Double-blind, Randomized Controlled Phase II Trial on the Efficacy and Safety of Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)[NCT04335071] | Phase 2 | 5 participants (Actual) | Interventional | 2020-04-26 | Terminated (stopped due to "1.) Not possible to recruit the planned number of patients during the planned study period; 2.) Dexamethason was included in the standard of care for the study population during the course of the study and inclusion criteria could no longer be met.") | ||
| A Phase II, Randomized, Double-blind, Placebo Controlled Study of Tocilizumab in Patients With Giant Cell Arteritis[NCT01450137] | Phase 2 | 30 participants (Actual) | Interventional | 2011-09-30 | Completed | ||
| A Randomized, Double-Masked, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Infliximab in Subjects With Giant Cell Arteritis[NCT00076726] | Phase 2 | 44 participants (Actual) | Interventional | 2003-11-30 | Terminated (stopped due to Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative glucocorticosteroid dosage) | ||
| Is the Melanocortin System Involved in Inflammatory Resolution[NCT05681676] | 9 participants (Actual) | Observational | 2012-03-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
cumulative weight-adapted prednisolone dose (NCT01450137)
Timeframe: 12 months
| Intervention | mg/kg (Median) |
|---|---|
| Tocilizumab | 43 |
| Placebo | 110 |
(NCT01450137)
Timeframe: 12 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Tocilizumab | 17 |
| Placebo | 4 |
(NCT01450137)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Tocilizumab | 17 |
| Placebo | 2 |
(NCT01450137)
Timeframe: 12 months
| Intervention | Weeks (Mean) |
|---|---|
| Tocilizumab | 50 |
| Placebo | 25 |
36 reviews available for prednisolone and Aortic Arteritis, Giant Cell
| Article | Year |
|---|---|
COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia.
Topics: Cardiovascular Diseases; COVID-19; Giant Cell Arteritis; Glucocorticoids; Humans; Hypertension; Lefl | 2022 |
An update on polymyalgia rheumatica.
Topics: Antirheumatic Agents; Biological Products; Biomarkers; Female; Giant Cell Arteritis; Glucocorticoids | 2022 |
[Inflammatory Muscle Pain: Polymyalgia Rheumatica with or without Large Vessel Vasculitis].
Topics: Aged; Antibodies, Monoclonal, Humanized; Blindness; Diagnosis, Differential; Fatigue; Female; Giant | 2020 |
Tocilizumab for the treatment of giant cell arteritis.
Topics: Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal, Humanized; Female; Giant Cell Arteritis; H | 2018 |
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dap | 2014 |
Giant cell arteritis.
Topics: Aged; Cyclophosphamide; Diagnostic Imaging; Drug Therapy, Combination; Female; Giant Cell Arteritis; | 2013 |
[Temporal arteritis: do not rely on the erythrocyte sedimentation rate].
Topics: Aged; Aged, 80 and over; Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Arteritis; | 2015 |
[Polymyalgia rheumatica and giant cell arteritis. New aspects in diagnosis and treatment].
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differe | 2008 |
Aortic complications of giant cell arteritis: a diagnostic and management dilemma.
Topics: Aged; Angiography; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Valve Insufficiency; Aortiti | 2010 |
Gastrointestinal symptoms and granulomatous vasculitis involving the liver in giant cell arteritis: a case report and review of the literature.
Topics: Aged; Anti-Inflammatory Agents; Blood Sedimentation; Female; Fever; Gastrointestinal Diseases; Giant | 2011 |
Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Aspirin; Biopsy; | 2012 |
Managing the patient with polymyalgia.
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Giant Cell Arteritis; Humans; Incidence; Mi | 2002 |
Polymyalgia rheumatica and temporal arteritis: evidence and guidelines for diagnosis and management in older people.
Topics: Aged; Aged, 80 and over; Algorithms; Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Middle | 2003 |
[Dementia due to cerebral vasculitis].
Topics: Anti-Inflammatory Agents; Bacterial Infections; Cyclophosphamide; Dementia; Drug Therapy, Combinatio | 2004 |
[Temporal arteritis].
Topics: Autoimmunity; Blood Sedimentation; Elastic Tissue; Endothelium, Vascular; Giant Cell Arteritis; Gluc | 2005 |
Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Mur | 2005 |
Giant cell arteritis: diagnosing and treating inflammatory disease in older adults.
Topics: Aged; Giant Cell Arteritis; Glucocorticoids; Humans; Middle Aged; Optic Neuropathy, Ischemic; Physic | 2005 |
Polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Polymy | 2006 |
[Polymyalgia rheumatica and giant-cell temporal arteritis].
Topics: Anti-Inflammatory Agents; Drug Administration Schedule; Giant Cell Arteritis; Humans; Polymyalgia Rh | 2006 |
[Diagnosis and therapy for polymyalgia rheumatica].
Topics: Antibodies, Monoclonal; Biomarkers; Blood Sedimentation; C-Reactive Protein; Diagnosis, Differential | 2007 |
[Temporal arteritis].
Topics: Drug Therapy, Combination; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Prednisolone | 1994 |
Diagnosis and management of temporal arteritis: a review and case report.
Topics: Administration, Oral; Aged; Biopsy; Diagnosis, Differential; Female; Fundus Oculi; Giant Cell Arteri | 1993 |
The management of polymyalgia rheumatica and giant cell arteritis.
Topics: Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone | 1993 |
[Temporal arteritis].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cyclophosphamide; Female; Giant Cell Arteritis; Humans; | 1993 |
Psychiatric aspects of temporal arteritis: a case report and review of the literature.
Topics: Aged; Biopsy; Blood Sedimentation; Cognition Disorders; Diagnosis, Differential; Female; Geriatric A | 1997 |
[Polymyalgia rheumatica].
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Giant Cell Arteritis; Humans; Polymyalgia Rheumat | 1999 |
Vasculitis--diagnosis and treatment.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Child; Female; Giant Cell A | 1999 |
[Temporal arteritis (giant cell arteritis)].
Topics: Autoimmunity; Cytokines; Diagnosis, Differential; Giant Cell Arteritis; Humans; Prednisolone; Progno | 2000 |
[Temporal arteritis(giant cell arteritis)].
Topics: Diagnosis, Differential; Giant Cell Arteritis; Humans; Immunity, Cellular; Prednisolone; Prognosis | 2001 |
[Temporal arteritis with giant cells].
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Giant Cell Arteritis; Giant Cells; Humans; Predni | 2001 |
Treatment of giant-cell arteritis: where we have been and why we must move on.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Aortic Aneurysm; Azathioprine; Drug Therapy, Combina | 2002 |
Giant cell arteritis in general practice.
Topics: Aged; Blindness; Diagnosis, Differential; Female; Giant Cell Arteritis; Hematocrit; Humans; Male; Mi | 1976 |
Treatment of polymyalgia rheumatica/giant cell arteritis.
Topics: Drug Administration Schedule; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone | 1991 |
Giant cell arteritis (temporal arteritis) affecting the breast: report of two cases and review of published reports.
Topics: Aged; Breast; Breast Diseases; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Middle | 1990 |
A case of temporal arteritis with intrahepatic arterial involvement.
Topics: Aged; Bile Ducts; Biopsy; Female; Giant Cell Arteritis; Hepatic Artery; Humans; Hyperplasia; Liver; | 1989 |
[Temporal arteritis].
Topics: Carotid Arteries; Fever; Giant Cell Arteritis; Headache; Humans; Prednisolone; Prognosis; Radiograph | 1985 |
15 trials available for prednisolone and Aortic Arteritis, Giant Cell
| Article | Year |
|---|---|
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Multicenter Studies as Topic; Polymyalg | 2022 |
Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from Sweden.
Topics: Arthritis; Giant Cell Arteritis; Humans; Janus Kinase Inhibitors; Prednisolone; Sweden | 2023 |
Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritis.
Topics: Administration, Oral; Aged; Biomarkers; Delayed-Action Preparations; Dose-Response Relationship, Dru | 2019 |
Early variation of ultrasound halo sign with treatment and relation with clinical features in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Giant Cell Arteritis; Glucocorticoids; Hum | 2020 |
Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
Topics: Biopsy; Denmark; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Neoplasms; Osteo | 2017 |
A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis.
Topics: Delayed-Action Preparations; Drug Administration Schedule; Drug Compounding; Feasibility Studies; Fe | 2018 |
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Disease-Free Survival; Double-Bli | 2016 |
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Disease-Free Survival; Double-Bli | 2016 |
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Disease-Free Survival; Double-Bli | 2016 |
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Disease-Free Survival; Double-Bli | 2016 |
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Blood Sedimentation; C-Reactive Protein; Dou | 2007 |
[Etiology and treatment of temporal arteritis].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Diagnosis, Differential; Drug Therapy, Combination; | 1994 |
Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis.
Topics: Aged; Aged, 80 and over; Bone Density; Drug Administration Schedule; Female; Giant Cell Arteritis; H | 1993 |
The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.
Topics: Aged; Aged, 80 and over; Drug Administration Schedule; Female; Follow-Up Studies; Giant Cell Arterit | 1993 |
Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.
Topics: Adrenal Cortex Hormones; Aged; Color Vision Defects; Contrast Sensitivity; Female; Follow-Up Studies | 1999 |
Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients.
Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Giant Cell Arteritis; | 2001 |
Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Drug Therapy, Combi | 2002 |
The diagnosis and management of episcleritis and scleritis.
Topics: Arteritis; Arthritis, Rheumatoid; Behcet Syndrome; Clinical Trials as Topic; Deafness; Eczema; Epine | 1965 |
277 other studies available for prednisolone and Aortic Arteritis, Giant Cell
| Article | Year |
|---|---|
Glucocorticoid dosing and relapses in giant cell arteritis-a single centre cohort study.
Topics: Chronic Disease; Cohort Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisolone; Recurr | 2022 |
Early diagnosis in patients with polymyalgia rheumatica: is a fast track clinic a viable solution? Comment on: "Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiation" by Frølund et al. Join
Topics: Early Diagnosis; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone | 2021 |
Answer to Manzo et al. "Early diagnosis in patients with polymyalgia rheumatica: Is a fast track clinic a viable solution?" Joint Bone Spine 2021;88:105262.
Topics: Early Diagnosis; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone | 2021 |
Increased risk of thoracic aortic complications among patients with giant cell arteritis: a nationwide, population-based cohort study.
Topics: Aged; Aortic Aneurysm; Aortic Aneurysm, Thoracic; Aortic Dissection; Cohort Studies; Female; Giant C | 2022 |
Atypical presentation of giant cell arteritis associated with SIADH: a rare association.
Topics: Aged; Giant Cell Arteritis; Humans; Inappropriate ADH Syndrome; Male; Prednisolone; Temporal Arterie | 2021 |
Risk of adrenal insufficiency in patients with polymyalgia rheumatica versus patients with rheumatoid arthritis: A cross-sectional study.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Arthritis, Rheumatoid; Cross-Sectional Studies; | 2022 |
Efficacy of leflunomide as a steroid-sparing agent in treatment of Indian giant cell arteritis patients: A 2-year follow-up study.
Topics: Follow-Up Studies; Giant Cell Arteritis; Humans; Leflunomide; Prednisolone; Recurrence; Steroids | 2022 |
Tocilizumab for relapsing and remitting giant cell arteritis: a case series.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Female; Giant Cell Arteritis; Humans; Ma | 2022 |
Distinct gene signatures of monocytes and B cells in patients with giant cell arteritis: a longitudinal transcriptome analysis.
Topics: Gene Expression Profiling; Giant Cell Arteritis; Humans; Monocytes; Prednisolone; Takayasu Arteritis | 2023 |
Atypical giant cell arteritis presentations diagnosed with FDG-18 whole body PET imaging.
Topics: Aged; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Positron Emission To | 2023 |
An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists.
Topics: General Practitioners; Giant Cell Arteritis; Glucocorticoids; Humans; Polymyalgia Rheumatica; Predni | 2023 |
Granulocyte colony-stimulating factor-induced aortitis with temporal arteritis and monoarthritis.
Topics: Aortitis; Arthritis; Filgrastim; Giant Cell Arteritis; Granulocyte Colony-Stimulating Factor; Humans | 2023 |
Large-vessel vasculitis associated with PEGylated granulocyte-colony stimulating factor.
Topics: Aged; Aorta, Thoracic; Endometrial Neoplasms; Female; Filgrastim; Giant Cell Arteritis; Glucocortico | 2019 |
Scalp ulceration: a rare manifestation of giant cell arteritis.
Topics: Administration, Oral; Aged, 80 and over; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Necr | 2019 |
Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aged; Aged, 80 and over; Anti-Inflammatory Agent | 2020 |
Boundaries of a systemic disease: a protean presentation of giant cell arteritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cholestasis; Cough; Diagnosis, Differential; Drug | 2020 |
Candida albicans and Staphylococcus lugdunensis superinfection of liver cysts in a patient with autosomal dominant polycystic kidney disease under prednisolone treatment.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Cysts; Diffu | 2020 |
Comment on: Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach: reply.
Topics: Adrenal Insufficiency; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone; Prevalenc | 2020 |
Comment on: Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis - prevalence and clinical approach.
Topics: Adrenal Insufficiency; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone; Prevalenc | 2020 |
Refractory giant cell arteritis: the value of clinical symptoms and imaging.
Topics: Aged; Antibodies, Monoclonal, Humanized; Aorta; C-Reactive Protein; Carotid Arteries; Drug Resistanc | 2020 |
Glucocorticoid-Induced Hypocalcemia in a Patient with Established Hypoparathyroidism.
Topics: Calcium; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Hypocalcemia; Hypoparathyroidism; Mi | 2021 |
Giant Cell Arteritis Presenting with Ptosis and Diplopia.
Topics: Aged; Biopsy; Blepharoptosis; Diplopia; Giant Cell Arteritis; Humans; Male; Prednisolone; Temporal A | 2021 |
Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
Topics: Adipose Tissue, White; Age Factors; Aged; Aged, 80 and over; Aorta; Biopsy; Blood Pressure; Body Com | 2021 |
Scalp Necrosis in Giant Cell Arteritis.
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Necrosis; Prednisolone; Scalp Dermatose | 2021 |
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Female; Giant Cell | 2021 |
Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiation.
Topics: Early Detection of Cancer; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone; Retro | 2021 |
Prospective clinical and ultrasonographic assessment of the temporal artery in a patient with giant cell arteritis.
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisolone; Temporal Arteries; Ultras | 2022 |
A tale of two vasculitides: biopsy-proven giant cell arteritis followed by the independent development of renal-limited microscopic polyangiitis.
Topics: Female; Giant Cell Arteritis; Glomerulonephritis; Humans; Microscopic Polyangiitis; Prednisolone; Tr | 2017 |
[Ischaemic necrosis of the tongue due to temporal arteritis].
Topics: Aged, 80 and over; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Necrosis; Prednisolone; To | 2017 |
Giant Cell Arteritis with Carotidynia.
Topics: Aged; Aorta, Thoracic; Carotid Artery Diseases; Female; Giant Cell Arteritis; Glucocorticoids; Human | 2017 |
Occult giant cell arteritis with an abnormal temporal artery finding and normal blood markers.
Topics: Aged; Biopsy; Diplopia; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Prednisolone; Tempora | 2017 |
Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia.
Topics: Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; | 2017 |
Skin-limited arteritis of small muscular arteries with giant cell-rich granulomatous inflammation in a patient with polymyalgia rheumatica.
Topics: Aged; Arteries; Fatal Outcome; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Polymyalgia Rh | 2018 |
Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial.
Topics: Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Giant Cell Arteritis; Glucoco | 2018 |
Diffuse large vessel giant cell arteritis found by
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Nausea | 2019 |
Leflunomide versus methotrexate in treatment of giant cell arteritis: comparison of efficacy, safety, and drug survival.
Topics: Aged; Antirheumatic Agents; Dose-Response Relationship, Drug; Drug Monitoring; Female; Giant Cell Ar | 2019 |
Diffusion Weighted Whole Body Imaging with Background Body Signal Suppression (DWIBS) Was Useful for the Diagnosis and Follow-up of Giant Cell Arteritis.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Aorta, Abdominal; Diffusion Magnetic Resonance | 2019 |
Chronic Cough in a 70-Year-Old Woman.
Topics: Aged; Anti-Inflammatory Agents; Aorta; C-Reactive Protein; Cough; Diagnosis, Differential; Female; F | 2019 |
Real pain in the neck: giant cell arteritis presenting with non-necrotising fasciitis and fever.
Topics: Aged, 80 and over; Fasciitis; Female; Fever; Giant Cell Arteritis; Humans; Magnetic Resonance Imagin | 2019 |
Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; England; Female; Giant Cell Arteritis; Gl | 2019 |
High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Angiopoietin-2; Biomarkers; C-Reactive Protein; Enzyme-Linked Immunosorbent | 2020 |
Reduction in stiffness of proximal leg muscles during the first 6 months of glucocorticoid therapy for giant cell arteritis: A pilot study using shear wave elastography.
Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Elasticity Imaging Techniques; Female; | 2019 |
Olanzapine as a cause of peripheric edema in an elderly man.
Topics: Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Edema; Giant Cell Arteritis; Glucocorticoi | 2013 |
Giant cell arteritis.
Topics: Administration, Oral; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Middle Aged; O | 2014 |
Extensive intracranial involvement with multiple dissections in a case of giant cell arteritis.
Topics: Anti-Inflammatory Agents; Aortic Dissection; Carotid Artery, Internal; Cerebral Angiography; Giant C | 2014 |
A giant cause of stroke.
Topics: Aged, 80 and over; Blood Sedimentation; Brain; Giant Cell Arteritis; Glucocorticoids; Humans; Magnet | 2014 |
Diagnostic and treatment challenges in giant cell arteritis - Authors' reply.
Topics: Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Optic Neuropathy, Ischemic; Predniso | 2014 |
Diagnostic and treatment challenges in giant cell arteritis.
Topics: Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Optic Neuropathy, Ischemic; Predniso | 2014 |
Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.
Topics: Age Distribution; Age Factors; Aged; Comorbidity; Databases, Factual; Drug Prescriptions; Female; Gi | 2015 |
Inflammatory Pseudo-tumour Orbitae (PTO): An Atypical Manifestation of Giant Cell Arteritis (GCA).
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Giant Cell Arteritis; Humans; Male; Orbital | 2015 |
[Giant cell arteritis diagnosed by PET-CT scan].
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Positron Emission Tom | 2014 |
Extra-cranial giant cell arteritis: a diagnostic challenge.
Topics: Aged; C-Reactive Protein; Female; Giant Cell Arteritis; Humans; Methotrexate; Middle Aged; Platelet | 2015 |
[Medial longitudinal fasciculus (MLF) syndrome in a patient with giant cell arteritis].
Topics: Administration, Oral; Aged; Cerebral Infarction; Diffusion Magnetic Resonance Imaging; Diplopia; Fem | 2015 |
Forehead necrosis, one of the many facades of giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Blindness; Cognition Disorders; Female; Forehead; | 2015 |
Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study.
Topics: Administration, Oral; Aged; Biopsy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gia | 2016 |
Isolated aortitis: a rare cause of febrile illness.
Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Aortitis; Diagnosis, Differential; Female; Fever; | 2015 |
Cotton-Wool Spots Associated With Mild Nonprogressive Visual Loss.
Topics: Administration, Oral; Aged; Biopsy; Disease Progression; Fluorescein Angiography; Giant Cell Arterit | 2015 |
Acute Myeloid Leukemia Complicated by Giant Cell Arteritis.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2016 |
IMAGES IN CLINICAL MEDICINE. Scalp Necrosis Associated with Giant-Cell Arteritis.
Topics: Aged; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Necrosis; Prednisolone; Scalp | 2016 |
Hypertrophic Pachymeningitis as a Potential Cause of Headache Associated with Temporal Arteritis.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Dura Mater; Giant Cell Arteritis; Headache; Humans; Hyp | 2016 |
Temporal arteritis with erythrocyte sedimentation rate <50 mm/h: a clinical reminder.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Blood Sedimentation; Giant Cell Arteritis; Headache; Humans; | 2016 |
Case of giant cell arteritis as a manifestation of immunoglobulin G4-related disease.
Topics: Administration, Oral; Autoimmune Diseases; Female; Forehead; Giant Cell Arteritis; Glucocorticoids; | 2016 |
[Brain stem infarction, temporal headache, and elevated inflammatory parameters in a 74-year-old man].
Topics: Aged; Anti-Inflammatory Agents; Brain Stem Infarctions; Diagnosis, Differential; Encephalitis; Giant | 2016 |
Diagnosing an atypical site of giant cell arteritis with magnetic resonance angiography: a case report.
Topics: Aged; Anti-Inflammatory Agents; Fever; Giant Cell Arteritis; Glucocorticoids; Headache; Humans; Live | 2016 |
Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
Topics: Adult; Aged; Aged, 80 and over; Comorbidity; Denmark; Diabetes Mellitus; Female; Giant Cell Arteriti | 2017 |
Visual disturbance with systemic symptoms: old lessons revisited.
Topics: Aged; Anti-Bacterial Agents; Diagnosis, Differential; Diagnostic Imaging; Endocarditis, Bacterial; G | 2016 |
Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Comorbidity; Diabetes Mellitus; Female; Follow-Up Stu | 2017 |
Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Diabetes Mellitus; Dose-Response Relationship, Drug; | 2017 |
Ocular Inflammation Associated with Polymyalgia Rheumatica without Concomitant Giant-Cell Arteritis: A Report of Three Cases.
Topics: Administration, Oral; Aged; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluoromethol | 2018 |
Duration of treatment after eye involvement in GCA.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Eye Diseases; Female; Follow-Up Studies; Giant Cell | 2008 |
Giant cell arteritis associated with lesion of the internal carotid artery: assessment of response to steroid therapy by magnetic resonance angiography.
Topics: Anti-Inflammatory Agents; Carotid Artery Diseases; Female; Giant Cell Arteritis; Humans; Magnetic Re | 2008 |
Polymyalgia rheumatica and its links with giant cell arteritis.
Topics: Anti-Inflammatory Agents; Comorbidity; Dexamethasone; Diagnosis, Differential; Giant Cell Arteritis; | 2008 |
Giant cell arteritis: not just a stroke in the eye.
Topics: Aspirin; Blindness; Drug Therapy, Combination; Early Diagnosis; Giant Cell Arteritis; Glucocorticoid | 2008 |
Bilateral brachial neuropathy and acute aortic dissection due to giant cell arteritis.
Topics: Anti-Inflammatory Agents; Aorta; Aortic Aneurysm; Aortic Dissection; Biopsy; Brachial Plexus; Brachi | 2009 |
[Necrosis of a hairy scalp as a first sign of arteritis temporalis].
Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Necrosis; Prednisolone; Scalp; | 2009 |
Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Follow-Up Studies; Giant Cell Arteritis; | 2010 |
Isolated granulomatous renal arteritis: a variant form of giant cell arteritis with few macrophages.
Topics: Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Macrophages; Middle Aged; Prednisolo | 2010 |
Abnormal chest X-ray in a patient with mononeuritis multiplex.
Topics: Aged; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Giant Cell Arteritis; Glucocorticoids; Humans; Mal | 2010 |
Giant cell (temporal) arteritis in Singapore: an occult case and the rationale of treatment.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Blindness; Female; Giant Cell Arteritis; Humans; Optic | 2010 |
Scalp necrosis secondary to giant-cell arteritis.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Necrosis; Prednis | 2010 |
Scalp necrosis in giant cell arteritis after initiation of therapeutic corticosteroids.
Topics: Aged, 80 and over; Biopsy; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Necrosis; Predniso | 2010 |
Giant cell (Temporal) arteritis with anterior ischemic optic neuropathy: a biopsy-proven case in Taiwan.
Topics: Aged; Biopsy; Blood Sedimentation; C-Reactive Protein; Giant Cell Arteritis; Humans; Male; Optic Neu | 2010 |
Two cases of recurrent stroke in treated giant cell arteritis: diagnostic and therapeutic dilemmas.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Midd | 2010 |
Giant cell arteritis in Mumbai.
Topics: Aged; Biopsy; Female; Follow-Up Studies; Giant Cell Arteritis; Glucocorticoids; Humans; India; Male; | 2010 |
Reduction in jaw opening: a neglected symptom of giant cell arteritis.
Topics: Aged; Craniomandibular Disorders; Diagnostic Errors; Female; Giant Cell Arteritis; Glucocorticoids; | 2011 |
A nonproductive cough that would give most people a headache, but not this patient!
Topics: Aorta; Cough; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Middle Aged; Prednisolone; Temp | 2011 |
Cluster headache or giant cell arteritis?
Topics: Aged; Anti-Inflammatory Agents; Cluster Headache; Diagnosis, Differential; Female; Giant Cell Arteri | 2008 |
[Report from the 11th Tokai Chapter Educational Seminar: 81 year old female with headache and fatigue of unknown cause, developing chest pain and hemiplegia during treatment].
Topics: Aged, 80 and over; Biopsy; Cerebral Infarction; Female; Giant Cell Arteritis; Humans; Prednisolone; | 2011 |
[Tongue necrosis as first clinical manifestation of Horton giant cell arteritis].
Topics: Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Necrosis; Optic Neuritis; Prednisolone; Tong | 2011 |
PMR and GCA: steroids or bust.
Topics: Aged; Antirheumatic Agents; Biological Products; Female; Giant Cell Arteritis; Glucocorticoids; Huma | 2012 |
Diagnosis and management of giant cell arteritis.
Topics: Administration, Oral; Anti-Inflammatory Agents; Aspirin; Biopsy; Giant Cell Arteritis; Glucocorticoi | 2012 |
Myopericarditis in giant cell arteritis: case report of diagnostic dilemma and review of literature.
Topics: Aged; Anti-Inflammatory Agents; Chest Pain; Coronary Angiography; Diagnosis, Differential; Echocardi | 2012 |
A case of Takayasu arteritis diagnosed at early-phase of disease by conventional CT scanning.
Topics: Adult; Aorta; Aortitis; Atherosclerosis; Azathioprine; Behcet Syndrome; Diagnosis, Differential; Dos | 2012 |
[The diagnostic risk of overlooking temporal arteritis].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Blood Sedimentation; C-Reactive Protein; | 2012 |
Lingual arteritis in an elderly woman.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Prednisolon | 2002 |
[Corticosteroid saving-up in giant cell arteritis?].
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Azathioprine; Cycloph | 2002 |
[Ophthalmological emergencies. 2. Trauma and acute loss of vision].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents; Blindness; Burns, Che | 2002 |
Recurrent angiolymphoid hyperplasia with eosinophilia mimicking temporal arteritis associated with nephrotic syndrome.
Topics: Adult; Angiolymphoid Hyperplasia with Eosinophilia; Diagnosis, Differential; Giant Cell Arteritis; G | 2003 |
Bilateral scalp necrosis with giant cell arteritis.
Topics: Aged; Alprostadil; Biopsy, Needle; Carotid Stenosis; Drug Therapy, Combination; Female; Follow-Up St | 2003 |
Giant cell arteritis presenting as a periorbital pain syndrome and a submandibular mass.
Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Headache; Humans; Magnetic Resonance Im | 2003 |
Pericardial and pleural effusion in giant cell arteritis.
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Pericardial Effusion; Pleural Effusion; | 2003 |
Case report: acute spontaneous Achilles tendon rupture in a patient with giant cell arteritis.
Topics: Achilles Tendon; Aged; Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Male; Prednisolone; R | 2003 |
[Case report on temporal arteritis treated with prednisolone].
Topics: Arteritis; Giant Cell Arteritis; Humans; Prednisolone | 1957 |
Temporal arteritis treated with prednisolone.
Topics: Arteritis; Giant Cell Arteritis; Humans; Prednisolone | 1957 |
Temporal arteritis. A report of two cases without systemic symptoms.
Topics: Carotid Arteries; Carotid Artery Diseases; Disease; Giant Cell Arteritis; Headache; Humans; Predniso | 1960 |
ALLERGY TO ACTH OF ANIMAL AND HUMAN ORIGIN.
Topics: Adrenocorticotropic Hormone; Anaphylaxis; Arthritis; Arthritis, Rheumatoid; Asthma; Cyanosis; Dermat | 1963 |
LOSS OF VISION FROM CRANIAL ARTERITIS WITHOUT OTHER SYMPTOMS.
Topics: Arteritis; Biopsy; Blindness; Blood Sedimentation; Diagnosis; Drug Therapy; Geriatrics; Giant Cell A | 1964 |
POLYMYALGIA RHEUMATICA.
Topics: Diagnosis, Differential; Drug Therapy; Giant Cell Arteritis; Humans; Myositis; Polymyalgia Rheumatic | 1965 |
Neovascularization around the optic nerve in giant cell arteritis.
Topics: Aged; Aspirin; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Male; Neovascularization, P | 2003 |
Giant cell arteritis (temporal arteritis, cranial arteritis) and a case from Singapore.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aortic Aneurysm; Aortic Dissection; Blindness; Fa | 2003 |
[Treatment and diagnosis of polymyalgia rheumatica and temporal arteritis].
Topics: Aged; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle | 2003 |
[Polymyalgia rheumatica and questionnaires].
Topics: Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Predni | 2004 |
Progressive visual loss in a patient with presumed temporal arteritis despite treatment: how to make the diagnosis.
Topics: Aged; Biopsy; Carotid Artery, External; Disease Progression; Female; Giant Cell Arteritis; Glucocort | 2004 |
Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Biomarkers; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cel | 2004 |
Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Cyclosporine; Drug Therapy, Combination; Female; | 2004 |
Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.
Topics: Blindness; Blood; Choroid Diseases; Fluorescein Angiography; Giant Cell Arteritis; Glucocorticoids; | 2005 |
Giant cell arteritis--presenting as stroke, transient ischaemic attack and dementia.
Topics: Aged; Blood Sedimentation; Dementia; Diagnosis, Differential; Family Practice; Giant Cell Arteritis; | 2005 |
Follicular bronchiolitis, an unusual cause of haemoptysis in giant cell arteritis.
Topics: Bronchiectasis; Bronchiolitis; Diagnosis, Differential; Giant Cell Arteritis; Glucocorticoids; Granu | 2006 |
Hepatic involvement in a patient with giant cell arteritis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Cholangiopancreatography, Endoscopic Retrograde; | 2006 |
Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis.
Topics: Anti-Inflammatory Agents; Biomarkers; Biopsy; Chemokine CCL2; Cytokines; DNA, Complementary; Follow- | 2006 |
Usefulness of angioplasty in a patient with biopsy-proven giant cell arteritis and severe stenosis of the superior mesenteric artery.
Topics: Aged; Angioplasty; Biopsy; Colon; Constriction, Pathologic; Cyclophosphamide; Drug Therapy, Combinat | 2006 |
Anterior segment ischaemia with giant cell arteritis.
Topics: Aged; Anterior Eye Segment; Biopsy; Blood Sedimentation; C-Reactive Protein; Drug Therapy, Combinati | 2006 |
[Temporal arteritis repeatedly associated with cranial neuropathies].
Topics: Aged; Female; Giant Cell Arteritis; Humans; Prednisolone; Pulse Therapy, Drug; Recurrence; Treatment | 2006 |
[Iatrogenic central serous chorioretinopathy during glucocorticoid therapy for temporal arteritis].
Topics: Aged; Anti-Inflammatory Agents; Chorioretinitis; Female; Fluorescein Angiography; Giant Cell Arterit | 2006 |
Kaposi sarcoma in a patient with giant cell arteritis.
Topics: Adrenal Cortex Hormones; Aged; Double-Blind Method; Female; Giant Cell Arteritis; Humans; Immunosupp | 2006 |
[Extradural lipomatosis after long-term treatment with steroids].
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Epidural Space; | 2006 |
Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
Topics: Aged; Anti-Inflammatory Agents; Blindness; Blood Sedimentation; C-Reactive Protein; Emergencies; Fem | 2006 |
Dry cough as first manifestation of giant-cell arteritis.
Topics: Aged; Anti-Inflammatory Agents; Cough; Giant Cell Arteritis; Humans; Male; Prednisolone | 2006 |
Summaries for patients. Adding infliximab to the treatment regimen for giant cell arteritis.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Double-Blind Method; Drug Therapy, Combinati | 2007 |
Giant cell arteritis with normal inflammatory markers.
Topics: Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Giant Cell Arteritis; Glucocortic | 2007 |
[Temporal arteritis presenting with headache and abducens nerve palsy. Report of a case].
Topics: Abducens Nerve Diseases; Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Giant Cell Arterit | 2007 |
Duration of treatment after eye involvement in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Drug Administration Schedule; Female; Giant Cell Arteritis; Humans; Male; O | 2007 |
Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Cerebral Arteries; Contrast Media; | 2008 |
Hyperostosis frontalis interna in a patient with giant cell arteritis.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Calcinosis; Female; Giant Cell Arteritis; Glucocorticoids; | 2008 |
Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?
Topics: Drug Therapy, Combination; Etanercept; Giant Cell Arteritis; Glucocorticoids; Humans; Immunoglobulin | 2008 |
Masked giant-cell arteritis.
Topics: Aged; Anemia; Aorta, Thoracic; Aortitis; Diagnosis, Differential; Diagnostic Errors; Female; Gastroi | 1980 |
[Coronary complications of Horton's disease: precipitating role of corticoids?].
Topics: Aged; Coronary Disease; Giant Cell Arteritis; Humans; Male; Myocardial Infarction; Prednisolone | 1984 |
Familial temporal arteritis.
Topics: Aged; Female; Giant Cell Arteritis; Humans; Male; Prednisolone | 1984 |
Coexistence of temporal arteritis/polymyalgia rheumatica and rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Polymyalgia | 1984 |
Polymyalgia rheumatica.
Topics: Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Male; Middle Age | 1983 |
Cranial arteritis: treatment is urgent.
Topics: Aged; Blindness; Giant Cell Arteritis; Humans; Prednisolone | 1984 |
The complications of systemic corticosteroid therapy in the elderly. A retrospective study.
Topics: Age Factors; Aged; Arthritis, Rheumatoid; Colitis, Ulcerative; Dose-Response Relationship, Drug; Fem | 1984 |
Temporal artery biopsy and corticosteroid treatment.
Topics: Giant Cell Arteritis; Humans; Prednisolone; Temporal Arteries | 1984 |
Polymyalgia rheumatica and corticosteroids: how much for how long?
Topics: Aged; Drug Administration Schedule; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymya | 1983 |
Giant cell arteritis.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Female; Giant Cell Arteritis; Humans; Immunity, Cellular | 1982 |
Diagnoses not to be missed: giant cell arteritis.
Topics: Aged; Biopsy; Blood Sedimentation; Giant Cell Arteritis; Headache; Humans; Pain; Polymyalgia Rheumat | 1982 |
[Therapy of giant cell arteritis].
Topics: Blindness; Blood Sedimentation; Giant Cell Arteritis; Humans; Prednisolone; Time Factors | 1982 |
Acute hearing loss in giant cell arteritis.
Topics: Giant Cell Arteritis; Hearing Loss, Sensorineural; Humans; Male; Middle Aged; Prednisolone | 1982 |
Visual failure in temporal arteritis.
Topics: Aged; Giant Cell Arteritis; Humans; Middle Aged; Prednisolone; Prognosis; Vision Disorders | 1982 |
An alternate-day corticosteroid regimen in maintenance therapy of giant cell arteritis.
Topics: Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisolone; Time Factors | 1981 |
Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids.
Topics: Aged; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednis | 1981 |
Acute lingual ischaemia complicating temporal arteries.
Topics: Aged; Giant Cell Arteritis; Humans; Ischemia; Male; Prednisolone; Tongue | 1981 |
Acute ocular hypotony. A rare complication of temporal arteritis.
Topics: Aged; Eye Diseases; Female; Giant Cell Arteritis; Headache; Humans; Intraocular Pressure; Male; Pred | 1981 |
The clinical pictures of giant cell arteritis. Temporal arteritis, polymyalgia rheumatica, and fever of unknown origin.
Topics: Aged; Biopsy; Blood Sedimentation; Fatigue; Female; Fever of Unknown Origin; Giant Cell Arteritis; H | 1980 |
Granulomatous vasculitis--a clinical presentation.
Topics: Adult; Autoimmune Diseases; Female; Giant Cell Arteritis; Humans; Prednisolone; Streptomycin | 1980 |
Polymyalgia rheumatica and giant cell arteritis.
Topics: Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone | 1995 |
Polymyalgia rheumatica, temporal arteritis and malignancy.
Topics: Adenocarcinoma; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Female; Giant Cell Arteritis; Hu | 1995 |
Polymyalgia rheumatica and giant cell arteritis. High dose corticosteroids are recommended.
Topics: Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone | 1995 |
Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; | 1995 |
Diagnosis and management of arteritis.
Topics: Blood Sedimentation; Drug Administration Schedule; Giant Cell Arteritis; Humans; Prednisolone | 1994 |
Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; Humans; Mal | 1994 |
A human T-cell lymphotropic virus type I carrier with temporal arteritis terminating in acute myelogenous leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Female; Giant Cell Arteritis; H | 1994 |
A district audit on the management of polymyalgia rheumatica and giant cell arteritis.
Topics: Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Medical Audit; Polymyalgia Rheumatic | 1994 |
The diagnosis and management of arteritis.
Topics: Arteritis; Giant Cell Arteritis; Humans; Polyarteritis Nodosa; Prednisolone; Tomography, X-Ray Compu | 1993 |
Reversible monocular blindness complicating Churg-Strauss syndrome.
Topics: Aged; Blindness; Churg-Strauss Syndrome; Female; Giant Cell Arteritis; Humans; Methylprednisolone; P | 1994 |
The diagnosis and management of arteritis.
Topics: Aged; Blood Sedimentation; Giant Cell Arteritis; Humans; Middle Aged; Prednisolone | 1994 |
Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
Topics: Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone; T-Lymphocyte Subsets | 1994 |
Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Aged, 80 and over; alpha 1-Antichymotrypsin; Blood Sedimentation; C-Reactive Protein; Female; | 1994 |
[Two ischemic cerebral accidents in treated Horton disease: caused by adrenal cortex hormone therapy?].
Topics: Cerebral Infarction; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednisolone | 1994 |
Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
Topics: Aged; Aged, 80 and over; CD4-CD8 Ratio; CD8 Antigens; Giant Cell Arteritis; Humans; Middle Aged; Ost | 1993 |
[Elevation of lipoprotein(a) in Horton disease].
Topics: Aged; Female; Giant Cell Arteritis; Humans; Lipoprotein(a); Prednisolone | 1993 |
Internuclear ophthalmoplegia and Horner's syndrome due to presumed giant cell arteritis.
Topics: Aged; Aged, 80 and over; Female; Giant Cell Arteritis; Horner Syndrome; Humans; Ophthalmoplegia; Pre | 1993 |
Plasma viscosity in giant cell arteritis as a predictor of disease activity.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; Blood Viscosity; C-Reactive Protein; Female; Fibrinoge | 1993 |
Intestinal perforation in temporal arteritis, associated with paroxysmal nocturnal hemoglobinuria.
Topics: Anti-Inflammatory Agents; Giant Cell Arteritis; Hemoglobinuria, Paroxysmal; Humans; Intestinal Perfo | 1996 |
Large vessel vasculitis without temporal artery involvement: isolated form of giant cell arteritis?
Topics: Aged; Angiography; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Arterial Occlusive Dise | 1996 |
Giant cell arteritis presenting as pulseless disease of the upper extremities.
Topics: Angiography; Anti-Inflammatory Agents; Arm; Diagnosis, Differential; Female; Giant Cell Arteritis; H | 1996 |
[Case of bilateral temporal skin ulcer with temporal arteritis].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Prednisolon | 1996 |
Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Oral prednisolone 40 mg daily is not adequate for temporal arteritis once vision is affected.
Topics: Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone; Vision | 1997 |
Giant cell arteritis--a case report.
Topics: Aged; Anti-Inflammatory Agents; Blood Sedimentation; Diagnosis, Differential; Facial Pain; Giant Cel | 1997 |
Polymyalgia rheumatica presenting after successful treatment of Cushing's disease.
Topics: Anti-Inflammatory Agents; Cushing Syndrome; Female; Giant Cell Arteritis; Glucocorticoids; Humans; H | 1998 |
Unilateral distal extremity swelling with pitting oedema in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Biopsy; Brain; Cerebral Angiography; Edema; Female; Follow-Up Studies; Foot | 1999 |
Clinical images: Skin necrosis in giant cell arteritis.
Topics: Biopsy; Blood Sedimentation; C-Reactive Protein; Giant Cell Arteritis; Humans; Male; Middle Aged; Ne | 1999 |
Giant cell arteritis associated with rheumatoid arthritis monitored by magnetic resonance angiography.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Female; Giant Cell Arteritis; | 1999 |
Giant cell (temporal) arteritis involving both external and internal carotid arteries.
Topics: Aged; Anti-Inflammatory Agents; Anticoagulants; Carotid Arteries; Cerebral Angiography; Female; Gian | 1999 |
[Rhizomelic pseudopolyarthritis: diagnosis, course, treatment].
Topics: Age Factors; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; | 1999 |
Cranial arteritis: a medical emergency with orofacial manifestations.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Emerge | 1999 |
Raynaud's phenomenon caused by giant cell arteritis. A case report.
Topics: Aged; Anti-Inflammatory Agents; Female; Giant Cell Arteritis; Humans; Prednisolone; Raynaud Disease; | 1999 |
Hypersensitivity pneumonitis associated with co-proxamol (paracetamol + dextropropoxyphene) therapy.
Topics: Acetaminophen; Alveolitis, Extrinsic Allergic; Analgesics; Anti-Inflammatory Agents; Dextropropoxyph | 1999 |
Giant cell arteritis causing bilateral sequential anterior ischaemic optic neuropathy--a case report.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Female; Giant Cell Arteritis; Humans; Opt | 2000 |
[Giant cell arteritis and scalp necrosis].
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Necrosis; Prednisolone; Scalp; Scalp De | 2000 |
[Blindness in temporal arteritis despite prednisolone treatment].
Topics: Aged; Anti-Inflammatory Agents; Blindness; Female; Giant Cell Arteritis; Humans; Prednisolone | 2000 |
No permanent reduction in bone mineral density during treatment of polymyalgia rheumatica and temporal arteritis using low dose corticosteroids.
Topics: Absorptiometry, Photon; Aged; Bone and Bones; Bone Density; Cross-Sectional Studies; Female; Giant C | 2000 |
Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chlorambucil; Drug Therapy, Combination; Female; Gian | 2000 |
Hypokalemic metabolic alkalosis secondary to giant cell arteritis.
Topics: Aged; Alkalosis; Anti-Inflammatory Agents; Giant Cell Arteritis; Humans; Hyperaldosteronism; Hypokal | 2000 |
Bilateral ocular ischemic syndrome secondary to giant cell arteritis.
Topics: Aged; Aged, 80 and over; Biopsy; Eye; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Hydroco | 2001 |
Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis.
Topics: Aged; Anemia, Hypochromic; Anti-Inflammatory Agents; Biopsy; Blood Sedimentation; Fatigue; Female; F | 2001 |
Positive temporal artery biopsy in a patient on therapeutic doses of steroids for six years.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Female; Follow-Up Studies; Giant Cell Arteritis; Glucocortic | 2001 |
Polymyalgia rheumatica and giant cell arteritis. Avoiding management traps.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Giant Cell Arter | 2001 |
[Polymyalgia rheumatica in general practice].
Topics: Aged; Anti-Inflammatory Agents; Clinical Competence; Diagnosis, Differential; Diagnostic Errors; Fam | 2001 |
Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Comorbidity; Dose-Response Relatio | 2002 |
[Hyperergic collagenoses. Clinical aspects, differential diagnosis and therapy (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Child; Collagen Diseases; Cyclophosphamide; Derm | 1977 |
Polymyalgia arteritica: a clinical review.
Topics: Aged; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheu | 1979 |
[Temporal arteritis].
Topics: Aged; Biopsy; Blindness; Female; Giant Cell Arteritis; Humans; Male; Ophthalmic Artery; Prednisolone | 1978 |
Treatment and prognosis in polymyalgia rheumatica and temporal arteritis. A ten-year survey of 53 patients.
Topics: Aged; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheuma | 1979 |
Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy.
Topics: Aged; Blood Platelets; Cell Survival; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Plate | 1979 |
Temporal arteritis. A 14-year epidemiological, clinical and prognostic study.
Topics: Aged; Blood Sedimentation; Cushing Syndrome; Eye Diseases; Female; Giant Cell Arteritis; Humans; Mal | 1979 |
[Polymyalgia arteritica--a phenomenon in giant cell arteritis].
Topics: Aged; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisolone; | 1979 |
Polymyalgia arteritica.
Topics: Giant Cell Arteritis; Humans; Prednisolone; Vision Disorders | 1977 |
Polymyalgia rheumatica and giant cell arteritis: a seven-year survey.
Topics: Aged; Diagnostic Errors; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Middle Aged; | 1975 |
Visual complications of polymyalgia rheumatica (polymyalgia arteritica).
Topics: Aged; Blindness; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumatica; Prednisolone; T | 1975 |
[Ulceronecrotic lesion of the face revealing Horton's disease].
Topics: Aged; Facial Dermatoses; Female; Giant Cell Arteritis; Humans; Necrosis; Prednisolone; Skin Ulcer | 1992 |
Haemorheological parameters in patients with retinal artery occlusion and anterior ischaemic optic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Blood Viscosity; Erythrocyte Aggregation; Erythrocyte Deformability; | 1992 |
Steroid treatment in giant cell arteritis.
Topics: Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Prednisolone | 1992 |
Pleural effusion as manifestation of temporal arteritis.
Topics: Aged; Female; Giant Cell Arteritis; Humans; Pleural Effusion; Prednisolone | 1992 |
Giant cell arteritis.
Topics: Drug Administration Schedule; Giant Cell Arteritis; Humans; Prednisolone | 1992 |
[Corticosteroid therapy in polymyalgia rheumatica and temporal arteritis is only suppressive].
Topics: Aged; Female; Giant Cell Arteritis; Humans; Palliative Care; Polymyalgia Rheumatica; Prednisolone; T | 1991 |
Prevention of blindness in giant cell arteritis by corticosteroid treatment.
Topics: Blindness; Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Prednisolone; Prospective | 1992 |
Treatable blindness in temporal arteritis.
Topics: Blindness; Giant Cell Arteritis; Humans; Optic Nerve Diseases; Prednisolone | 1992 |
[Headache and eyes: temporal arteritis].
Topics: Diagnosis, Differential; Giant Cell Arteritis; Headache; Humans; Prednisolone; Prognosis; Vision Dis | 1991 |
[Horton's disease].
Topics: Aged; Cluster Headache; Diagnosis, Differential; Erythema Nodosum; Female; Giant Cell Arteritis; Hum | 1991 |
Brainstem vascular accidents and cranial arteritis.
Topics: Aged; Blood Sedimentation; Brain Stem; Cerebrovascular Disorders; Female; Giant Cell Arteritis; Huma | 1991 |
Death from unsuspected diverticular disease in patients taking corticosteroids for polymyalgia rheumatica or giant cell arteritis.
Topics: Aged; Diverticulum, Colon; Female; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolon | 1991 |
[The diagnosis and treatment of temporal arteritis].
Topics: Aged; Cerebrovascular Circulation; Combined Modality Therapy; Giant Cell Arteritis; Humans; Male; Mi | 1991 |
von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Antigens; Biomarkers; Female; Follow-Up Studies; Giant Cell Arteritis; Huma | 1991 |
[The clinical manifestations of polymyalgia rheumatica].
Topics: Aged; Aged, 80 and over; Chronic Disease; Diagnosis, Differential; Female; Giant Cell Arteritis; Hum | 1991 |
[Functional diagnosis in follow-up of temporal arteritis treatment].
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Giant Cell Art | 1990 |
[Hemorheologic parameters in patients with giant cell arteritis before and after treatment with steroids].
Topics: Aged; Blood Viscosity; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Giant Cell Arteri | 1990 |
Temporal arteritis presenting as a submandibular swelling.
Topics: Aged; Female; Giant Cell Arteritis; Humans; Prednisolone; Submandibular Gland Diseases | 1990 |
[Steroid-sensitive cavitating pulmonary opacity in Horton's disease].
Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Pneumonia; Prednisolone; Tuberc | 1990 |
Orbital pseudotumour secondary to giant cell arteritis: an unreported condition.
Topics: Aged; Diplopia; Female; Giant Cell Arteritis; Humans; Orbital Diseases; Prednisolone | 1990 |
Treatment of polymyalgia rheumatica and giant cell arteritis.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Polymyalgia Rheumatica; Prednisolone | 1990 |
Basal and stimulated elastolytic activity of blood monocytes is increased in glucocorticoid-treated giant cell arteritis.
Topics: Adult; Aged; Aged, 80 and over; Cells, Cultured; Dexamethasone; Giant Cell Arteritis; Humans; Longit | 1990 |
Mononeuritis multiplex and occipital infarction complicating giant cell arteritis.
Topics: Aged; Blood Sedimentation; Cerebral Infarction; Female; Giant Cell Arteritis; Humans; Methylpredniso | 1989 |
Giant cell (temporal) arteritis following polyarteritis nodosa.
Topics: Female; Giant Cell Arteritis; Humans; Middle Aged; Polyarteritis Nodosa; Prednisolone | 1989 |
[Eye manifestations of Horton's disease].
Topics: Blepharoptosis; Diplopia; Eye Diseases; Giant Cell Arteritis; Humans; Prednisolone; Time Factors; Vi | 1989 |
Temporal arteritis. The Indian scene.
Topics: Aged; Biopsy; Developing Countries; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Prednis | 1989 |
[Interaction of rifampicin and prednisolone. Apropos of 2 cases occurring in Horton's disease].
Topics: Aged; Drug Interactions; Female; Giant Cell Arteritis; Humans; Male; Prednisolone; Rifampin | 1989 |
Bilateral internuclear ophthalmoplegia--an unusual initial presenting sign of giant cell arteritis.
Topics: Biopsy; Convergence, Ocular; Diplopia; Giant Cell Arteritis; Humans; Male; Middle Aged; Nystagmus, P | 1989 |
[A patient with temporal arteritis presenting corneal ulcer as his first symptom].
Topics: Aged; Corneal Ulcer; Cyclophosphamide; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Male | 1989 |
Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
Topics: Blood Sedimentation; C-Reactive Protein; Drug Administration Schedule; Giant Cell Arteritis; Humans; | 1989 |
Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.
Topics: Drug Administration Schedule; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone; Pr | 1989 |
Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study.
Topics: Aged; Alkaline Phosphatase; Blood Sedimentation; C-Reactive Protein; Chronic Disease; Female; gamma- | 1985 |
[Hepatic localization of Horton's disease or secondary cancer of the liver. Value of ultrasonic surveillance under corticotherapy].
Topics: Aged; Giant Cell Arteritis; Humans; Liver Diseases; Liver Neoplasms; Male; Prednisolone; Ultrasonogr | 1986 |
[Coronary localization of Horton's disease].
Topics: Aged; Coronary Disease; Giant Cell Arteritis; Humans; Male; Prednisolone | 1988 |
HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Female; Fluorescent Antibody Technique; Giant Cell Arteritis; HLA-DR Antige | 1988 |
Acute phase reactants in the initial phase of giant cell arteritis.
Topics: Acute-Phase Reaction; Aged; Blood Sedimentation; C-Reactive Protein; Female; Fibrinogen; Giant Cell | 1986 |
Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).
Topics: Aged; Drug Administration Schedule; Female; Giant Cell Arteritis; Humans; Male; Polymyalgia Rheumati | 1988 |
[Temporal arteritis--diagnosis and therapeutic control].
Topics: Dose-Response Relationship, Drug; Eye; Giant Cell Arteritis; Humans; Ischemia; Ophthalmodynamometry; | 1988 |
Steroid-responsive hearing loss in temporal arteritis.
Topics: Aged; Aged, 80 and over; Giant Cell Arteritis; Hearing Loss, Sensorineural; Humans; Male; Prednisolo | 1988 |
[Polymyalgia rheumatica and giant-cell arteritis].
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; Humans; Mal | 1988 |
Giant cell arteritis and systemic lupus erythematosus.
Topics: Female; Giant Cell Arteritis; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone | 1988 |
[Giant cell arteritis during steroid therapy].
Topics: Aged; Female; Giant Cell Arteritis; Humans; Prednisolone | 1988 |
Giant-cell arteritis and temporal arteritis.
Topics: Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisolone | 1987 |
[2 cases of Horton's giant cell arteritis].
Topics: Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Middle Aged; Prednisolone; Temp | 1987 |
Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica.
Topics: Drug Administration Schedule; Female; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumat | 1987 |
The sensation of facial swelling in temporal arteritis: a predictor for the development of visual disturbance.
Topics: Aged; Blindness; Face; Female; Giant Cell Arteritis; Humans; Male; Prednisolone | 1986 |
[A case of temporal arteritis].
Topics: Aged; Female; Giant Cell Arteritis; Humans; Prednisolone | 1987 |
Polymyalgia rheumatica.
Topics: Aged; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Prednisolone | 1986 |
Brain stem infarction as a complication of giant-cell arteritis.
Topics: Aged; Brain Stem; Cerebral Infarction; Female; Giant Cell Arteritis; Humans; Male; Prednisolone | 1986 |
Long-term corticosteroid treatment in giant cell arteritis.
Topics: Aged; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Prednisolone; Prospective Studi | 1986 |
Pyrexia in giant cell arteritis.
Topics: Aged; Female; Fever; Giant Cell Arteritis; Humans; Prednisolone | 1985 |
[Diagnosis and therapy of so-called temporal arteritis (Horton)].
Topics: Aged; Arteries; Diagnosis, Differential; Female; Giant Cell Arteritis; Head; Humans; Prednisolone | 1985 |
Steroid sensitive systemic disease with anaemia in the elderly: a manifestation of giant cell arteritis?
Topics: Age Factors; Aged; Anemia; Blood Viscosity; Female; Giant Cell Arteritis; Hemoglobins; Humans; Male; | 1985 |
Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.
Topics: Aged; Female; Giant Cell Arteritis; Humans; Male; Middle Aged; Oxyphenbutazone; Phenylbutazone; Poly | 1967 |
[Contributions on the clinical aspects and the diagnosis of cranial arteritis].
Topics: Aged; Biopsy; Blood Sedimentation; Cerebral Angiography; Dexamethasone; Diagnosis, Differential; Fem | 1968 |
Anterior ischaemic optic neuropathy. III. Treatment, prophylaxis, and differential diagnosis.
Topics: Acetazolamide; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Antihypertensive Agents; Arteri | 1974 |
[Letter: Temporal arteritis].
Topics: Giant Cell Arteritis; Humans; Prednisolone; Prednisone; Recurrence | 1973 |
[Case of temporal arteritis].
Topics: Aged; Giant Cell Arteritis; Humans; Male; Prednisolone | 1973 |
Dynamic tonometry. V. Further studies of the corneal indentation pulse in temporal arteritis.
Topics: Aged; Blood Sedimentation; Cornea; Embolism; Female; Giant Cell Arteritis; Humans; Intraocular Press | 1973 |
[Polymyalgia rheumatica].
Topics: Age Factors; Aged; Autoimmune Diseases; Azathioprine; Biopsy; Female; Giant Cell Arteritis; Humans; | 1974 |
Pericardial effusion and giant-cell arteritis.
Topics: Female; Giant Cell Arteritis; Humans; Middle Aged; Pericardial Effusion; Prednisolone; Temporal Arte | 1972 |
[Aortic arch syndrome caused by inflammatory vascular diseases].
Topics: Aged; Angiography; Aortic Arch Syndromes; Aortography; Arteritis; Autopsy; Axillary Artery; Blood Pr | 1972 |
Temporal arteritis. Occurrence of ocular complications 7 years after diagnosis.
Topics: Aged; Female; Fluorescein Angiography; Fundus Oculi; Giant Cell Arteritis; Humans; Ischemia; Middle | 1972 |
Blindness due to occlusive arterial disease ("visual strokes").
Topics: Aged; Blindness; Carotid Artery Thrombosis; Giant Cell Arteritis; Humans; Intracranial Embolism and | 1965 |
Peripheral vascular disease in the elderly.
Topics: Aged; Female; Giant Cell Arteritis; Humans; Leg Ulcer; Male; Occlusive Dressings; Prednisolone; Thro | 1971 |
[Headache in the temporal region].
Topics: Aged; Female; Giant Cell Arteritis; Headache; Humans; Male; Migraine Disorders; Polymyalgia Rheumati | 1968 |
The recognition and importance of cranial arteritis.
Topics: Blindness; Female; Giant Cell Arteritis; Headache; Humans; Male; Prednisolone; Prednisone; Vascular | 1966 |